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1 Introduction 
1.1 Nonylphenol 
The xenoestrogen nonylphenol-family (NP) is found nearly ubiquitously at low concentrations in a 
variety of environmental compartments. It has been reported in water samples from numerous 
locations worldwide (Blackburn and Waldock 1995; Ahel et al. 1996; Rudel et al. 1998; Potter et al. 
1999; Snyder et al. 1999; Kuch and Ballschmiter 2001), in raw sewage, final effluent, sludge and 
sediments, river water, groundwater, seawater and even in surface and drinking water (Ahel et al. 
1994; Ahel et al. 1994; Di Corcia et al. 1994; Petrovic et al. 2004; Shao et al. 2005), in a variety of 
other media including sediments (Marcomini et al. 1990; Bennie et al. 1997; Bennett and Metcalfe 
1998), air (Dachs et al. 1999; Van Ry et al. 2000), fish and molluscs (Lye et al. 1999; Ferrara et al. 
2001; Keith et al. 2001) and even human food (Guenther et al. 2002).  
The most common route of NPs entry into the environment is through detergents in wastewater. The 
group of non-ionic surfactants known as NPEOs contain the NP moiety and was typically used in 
domestic liquid laundry detergents, industrial liquid soaps and cleaners, cosmetics, paints, and as 
dispersing agents in pesticides and herbicides (APE Research Council, 2001). Because of its extensive 
use in cleansers, most NPEOs are discharged into the sewer system and make their way into 
wastewater treatment plants. Under anaerobic conditions such as those found in sewers, sediments, 
and certain treatment operations at wastewater treatment plants, NPEOs are biometabolised  to NPs. 
Commercial production of NPs for the synthesis of NPEO results in a mixture of NP isomers (Giger et 
al. 1984; Ekelund et al. 1993; Sweetman 1994; Bokern et al. 1998; Sekela et al. 1999). The basic 
structure of Nonylphenols (as example 4-n-nonylphenol) is shown in Fig. 1.1 
 
 
Figure 1.1: Structure of 4-n-nonylphenol  
 
The side chain contains nine carbon atoms and can be attached to phenol at different points on the 
phenylring, thus producing mainly para- besides ortho- isomers. Each is named according to the 
position of the chain attachment. Additionally, the carbon chain may be straight or branched in a 
variety of configurations, thus each different branching pattern of the carbon chain can represent a 
different NP isomer.  
European countries have banned the use of NPEOs since the 1980s because of their potential 
environmental toxicity issues (Renner 1997). NPs has also been implicated as an endocrine disrupter 
in higher animals (Soto et al. 1991; Gimeno et al. 1997). There is significant evidence that NPs acts as 
an estrogen mimic. Soto et al. (1991) found that human breast cancer cells that require estrogen for 
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proliferation would multiply in the presence of NPs. The exact mechanism by which NPs interfere 
with hormone activities is not clearly known, but one theory attributes the effect to both similar 
physicochemical properties and similar molecular structures of certain isomers of NPs and  the natural 
estrogen, estradiol (Thiele et al. 1997).  
NPs are of particular concern because it is persistent, toxic to aquatic organisms, and a potential 
endocrine disrupter. Effects on human and ecosystem health due to low concentration exposure to NPs 
are poorly understood and open to considerable debate.  
1.2 Aims of this study 
The purpose of this study was to obtain a better understanding of the behaviour, the characteristics, the 
metabolism and the metabolites or derivatives of NPs. In fact, the more information, the better the 
understanding of the risk of exposure for human health to NPs is obtained.  
The development of efficient molecular tools, making it possible to analyze individual bioconversion 
steps by well-characterized enzymes, such as cytochrome P450 monooxygenases, appeared rapidly 
critical for valuable toxicological predictions.  
The first aim of the present work was to establish a recombinant yeast cell culture, able to express the 
human proteins CYP2C19 and CYP2B6 (cytochromes P450) for model degradation studies. Two 
different systems were created; in the first, both yeast reductase and the respective cytochrome P450 
monooxygenase were over-expressed (both genes present on a plasmid), and in the second, yeast 
reductase was controlled at genomic level and the cytochrome P450 monooxygenase was over-
expressed (present on a plasmid). The transgenic yeast cell cultures should be necessary in order to 
perform metabolism studies with NPs. To verify protein expression and activity, first model 
metabolism experiments were executed with the substrates simazine (herbicide) and methoxychlor 
(insecticide) for which information regarding transformation by human CYP2C19 and CYP2B6 were 
published in the literature. The investigation addresses the following question: 
• Are the two yeast systems effective to metabolize xenobiotics in different rates? 
• Are the recombinant yeasts expressing active proteins? 
• Are CYP2C19 and CYP2B6 both able to metabolize NPs? 
• Is it possible to identify metabolites of NPs? 
 
NPs were detected in drinking water and wastewater, therefore they are subjected to all disinfection 
processes of the drinking water and wastewater treatment plant. The disinfection procedure often 
includes the use of sodium hypochlorite; during this process many by-products can be produced 
including chlorinated derivatives of NP. 
Thus the second aim of the present work was, to assess the xenohormone potency of different pure 
isomers of NPs and their mono-chlorinated and di-chlorinated derivatives. The mono and di-
chlorinated derivatives were synthesized and tested with regard to their xenohormone potency (YES 
and YAS assays).  
  1. Introduction 
- 3 - 
The investigation addresses the following questions: 
• Are different isomers of NPs differing regarding their xenohormone potency using the YES and 
YAS assays? 
• Are the corresponding mono- and di-chlorinated derivatives of different NP isomers differing 
regarding their xenohormone potency? 
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2 General Information 
2.1 Endocrine system 
2.1.1 General 
The endocrine system consists of a set of glands, and the hormones they produce, such as thyroxine, 
oestrogen, testosterone and adrenaline help to guide the development, growth, reproduction, and 
behaviour of animals and human beings via receptors at the target organs (Vander et al. 1998). 
Endocrine signaling thus, utilizes hormones, released by the glands into the bloodstream in order to 
elicit responses in other parts of the body. An endocrine system is found in most animals, including 
mammals, non-mammalian vertebrates (such as birds, fish, amphibians, and reptiles), and 
invertebrates (such as snails and insects).  
2.1.2 Hormones and hormone receptors 
Structurally, there are three basic types of hormones: 1) amines, including thyroids hormones, 2) 
steroids, including sex hormones, and 3) peptides, including insuline and growth hormones. Peptide 
and catecholamine hormones are water-soluble; therefore, with the exception of a few peptides, these 
hormones are transported simply in dissolved form in the plasma. In contrast, the steroid hormones 
and the thyroid hormones circulate in the blood largely bound to plasma proteins (Vander et al. 1998). 
Most biological responses to hormones are mediated through binding to cellular proteins called 
receptors. Cells, which do not have such a receptor, cannot be influenced directly by the corresponding 
hormone . 
Receptors interact with other cellular constituents to propagate the cellular response to the hormone 
signal (Barton and Andersen 1998). Hormones are chemical messengers that invoke profound changes 
within target cells. There are two fundamental mechanisms by which such changes occur:  
• Activation of enzymes and other dynamic molecules. Most enzymes shuttle between 
conformational states that are catalytically active versus inactive. Many hormones affect their 
target cells by inducing such transitions, usually causing an activation of one or more enzymes. 
Because enzymes are catalytically active and often serve to activate additional enzymes, a 
seemingly small change induced by hormone-receptor binding can lead to widespread 
consequences within the cell. 
• Modulation of gene expression: Stimulating transcription of a group of genes can lead to a burst 
of synthesis of new proteins. Similarly, if transcription of a group of previously active genes is 
shut off, the corresponding proteins will soon disappear from the cell. 
More specifically, when a receptor becomes bound to a hormone, it undergoes a conformational 
change, which allows it to interact with other components of the cells, leading ultimately to an 
alteration in the physiologic state of the cell (Vander et al. 1998). 
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2.1.3 Steroid and thyroid hormone receptors 
Steroid and thyroid hormone receptors are members of a "superfamily" of transcription factors. They 
are located inside target cells, in the cytoplasm or nucleus, and function as ligand-dependent 
transcription factors, so the hormone-receptor complex binds to promoter regions of responsive genes 
and stimulates or sometimes inhibits transcription of those genes. In some cases, multiple forms of a 
given receptor are expressed in cells, adding to the complexity of the response. All of these receptors 
are composed of a single polypeptide chain that has, in the simplest analysis, three distinct domains:  
• The amino-terminus: in most cases, this region is involved in activating or stimulating 
transcription by interacting with other components of the transcriptional machinery. The sequence 
is highly variable among different receptors. 
• DNA binding domain: amino acids in this region are responsible for binding of the receptor to 
specific sequences of DNA.  
• The carboxy-terminus or ligand-binding domain: this is the region that binds hormones. 
In addition to these three core domains, two other important regions of the receptor protein are a 
nuclear localization sequence, which targets the protein to nucleus, and a dimerization domain, which 
is responsible for latching two receptors together in a form capable of binding to DNA (Germain et al. 
2003). 
 
Figure 2.2.1: Mechanism of steroid hormone and steroid hormone receptor (PEP 2003). 
Steroid hormones can enter the cells by diffusion. They bind to the hormone receptors in the cytoplasm and the 
complex moves into the nucleus where it interacts with DNA to initiate protein synthesis. 
2.1.4 Hormone-Receptor Binding and Interactions with DNA 
Due to their lipid character, steroid hormones enter the cell by simple diffusion across the plasma 
membrane. Thyroid hormones enter the cell by facilitated diffusion. The receptors exist either in the 
cytoplasm or nucleus, which is where they meet the hormone. When a hormone binds to a receptor, a 
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characteristic series of events occurs (Vander et al. 1998; Kimbrel and McDonnell 2003):  
• Receptor activation: is the term used to describe conformational changes in the structure of the 
receptor induced by binding hormones. The major consequence of activation is that the receptor 
becomes competent to bind to DNA. 
• Activated receptors bind to "hormone response elements" which are short specific sequences 
of the DNA, located in promoters of hormone-responsive genes. 
• Transcription of those genes to which the receptor is bound is affected. Most commonly, 
receptor binding stimulates transcription. The hormone-receptor complex thus functions as a 
transcription factor. 
A schematic mechanism of the interaction steroid hormone and hormone receptor and the cascade of 
events is shown in Fig. 2.1. 
2.2 Endocrine disrupter compounds (EDCs) 
2.2.1 Definition of EDCs 
The International Programme for Chemical Safety has established the following definition for 
endocrine disrupters: 
“Endocrine disrupters have been defined as exogenous substances that alter function(s) of the 
endocrine system and consequently cause adverse health effects in an intact organism, or its progeny, 
or (sub-) populations.” 
Endocrine disrupters interfere with the functioning of the endocrine system (Katzenellenbogen and 
Muthyala 2003), in at least three possible ways: 
• by mimicking the action of a naturally-produced hormone, such as estrogen or testosterone, and 
thereby setting off similar chemical reactions in the body; 
• by blocking the receptors in cells receiving the hormones (hormone receptors), thereby preventing 
the action of natural hormones;  
• by affecting the synthesis, transport, metabolism and excretion of hormones, thus altering the 
concentrations of natural hormones.  
2.2.2 Classification of EDCs  
There are two classes of substances, which can cause endocrine disruption (Katzenellenbogen and 
Muthyala 2003): 
• Natural hormones, which include estrogen, progesterone and testosterone found naturally in the 
bodies of humans and animals, and phytoestrogens, substances contained in some plants, which 
display oestrogen-like activity when ingested by the body. Natural hormones are believed to be 
easily broken down in the human body; thus, they do not accumulate in body tissues, which is the 
case with certain man-made (anthropogenic) substances. 
• Man-made substances which include:  
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• synthetically produced hormones, including those hormones which are identical to natural 
hormones, such as oral contraceptives, hormone-replacement treatments and some animal feed 
additives, which have been designed intentionally to interfere with and modulate the 
endocrine system; 
• man-made chemicals (thousands of new and existing man-made chemicals exist) designed 
for uses in industry, such as in industrial cleaning agents, in agriculture, in certain pesticides, 
and in consumer goods such as in plastic additives. This group also includes chemicals 
produced as a by-product of industrial processes. Some of the potential environmental EDCs 
are persistent and are found comparatively ubiquitously in the environment. 
Among the man-made chemicals, the following compounds have been shown to possess estrogenic 
potency: p-tertalkyl phenols, most notably octylphenol and nonylphenol, the hydrophobic core of the 
polyethoxylate nonionic detergents; dialkyl phthalates used as plasticizers and bisphenol A, a 
(monomer) component of thermostable polycarbonate polymers; chlorinated aromatic substances, 
insecticides and industrial fluids such as methoxychlor and PCBs (polychlorinated biphenyls) and 
dioxins. 
2.2.3 Nonylphenol as endocrine disrupter 
There has been increasing public concern for the presence in the environment, of chemicals able to 
affect the hormonal system, producing an adverse effect on both aquatic and terrestrial species (Fry 
1995; Sumpter 1995; Nimrod and Benson 1996); furthermore, human possibly decreased sperm counts 
and male reproductive capabilities have been observed over the past years (Toppari et al. 1996; Swan 
et al. 2000; Carreno et al. 2007). These chemicals do not always resemble the structure of 17-"-
estradiol (E2), but through a possible comparable mechanism of action they can mimic or block 
natural hormones with agonistic or antagonistic effects on their receptors (Zacharewski 1997).One of 
the major chemicals able to bind the estrogen receptor (ER) and elicit estrogenic actions in vivo and in 
vitro is nonylphenol (NP) (Mueller and Kim 1978; Soto et al. 1991; White et al. 1994). The commonly 
used NP is a technical mixture of approximately (Lewis 1996) 20 para-substituted isomers, with 
differently branched alkyl chains (Tabira et al. 1999; Kim et al. 2004; Thiele et al. 2004; Ru[ss] et al. 
2005). The exact mechanism by which NP interferes with hormone activities is not clearly defined; 
one theory was already mentioned before (Thiele et al. 1997). Certain patterns of branched carbon 
chains on an NP molecule closely resemble the structural shape of estradiol (estrogen). This fact 
emphasizes that certain isomers of NP may be estrogenic mimics while others may not.  
Many studies have been conducted about the structure-potency relationship of NP as endocrine 
disrupter. Some studies have shown that the isomers of NP, having highest affinity for the ER, have a 
para-substituted side chain and that the estrogenic potency and affinity was less for substances with 
more than one side chain (Routledge and Sumpter 1997; Tabira et al. 1999). Furthermore the 
estrogenic potency is higher for alkyl phenols branched on the !-carbon and with a side chain length 
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of eight-nine carbons (Routledge and Sumpter 1997). This implies that different isomers of 
nonylphenol can have different estrogenic potency. Because the isomeric composition of p-NP differs 
distinctly among producers (Ru[ss] et al. 2005), and the environmental composition can lead to a shift 
isomeric composition of p-NP (Kim et al. 2005), it is necessary to know the estrogenic potency of 
individual isomers for understanding interactions of alkylphenols with the ER and for environmental 
risk assessment (Preuss et al. 2006).  
Because of its potential risk for human health and its ubiquitous presence in the environment, further 
studies must be carried out to understand whether NP can cause adverse effects on human life. This 
can be achieved by creating a simplified model (a recombinant yeast, transformed with human 
cytochrome P450) to carry on metabolism studies on this substance. Furthermore, because of the 
presence of NP in drinking water and a widely used disinfection method is the use of sodium 
hypochlorite, the assessment of the xenohormone properties of its chlorinated derivatives is necessary. 
2.3 Cytochrome P450 monooxigenase and reductase. 
2.3.1 Cytochrome P450 monooxigenase 
The cytochrome P450 superfamily of membrane-bound heme-thiolate enzymes is currently known to 
comprise over 300 different proteins which have been classified into 36 families and subfamilies based 
on their amino acid sequence homologies (Lewis 1996). These proteins function primarily in the 
oxidative catalysis of endogenous and xenobiotic compounds. They largely serve to detoxify or 
inactivate excessive residues of xenobiotic compounds, among which are drugs, pesticides, other 
environmental pollutants, steroid hormones, and fatty acids.  
The P450-dependent mixed-function oxidases catalyze a wide variety of reactions including 
epoxidations, N-dealkylations, O-delakylations, S-oxidations and hydroxylations of aliphatic and 
aromatic substrates. The diversity of the reactions catalyzed can be understood by considering that the 
initial reaction in all cases involves insertion of an oxygen atom into the substrate to form mainly a 
hydroxylated intermediate, which can then, depending on the nature of the substrate and the stability 
of the intermediate, undergo dealkylation, deamination, etc (Hollenberg 1992). 
The catalytic centre in cytochrome P450s is located around a porphyrin–heme complex confined 
within different amino acid sequences, which alter the topography of the active site and allow the 
binding of considerably diverse substrates.  
The most common reaction catalysed by P450 enzymes is a monooxygenase reaction, i.e.insertion of 
one atom of oxygen into a substrate while the other oxygen atom is reduced to water. Cytochromes 
P450 are not self-sufficient enzymes and, for function, eukaryotic microsomal forms require NADPH 
cytochrome P450 reductase (CPR) as an electron donor (see Fig. 2.2). 
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Figure 2.2.2: Mechanism of cytochrome P450 monooxigenase and reductase 
The cytochrome P450 monooxygenase is anchored at the membrane through the N-terminal site of the enzyme. 
The NADPH gives one electron to the FAD site of the reductase which donates it to the FMN site. The electron 
is given to the heme group of the CYP P450 monooxygenase and the substrate is oxygenated. 
To perform catalysis, P450 must receive two electrons from NADPH via CPR. P450s are generally 
divided into two major classes: class I family includes bacterial and mitochondrial P450s, which use a 
two-component shuttle system consisting of an iron-sulfur protein (ferredoxin) and ferredoxin 
reductase; class II enzymes are the microsomal P450s, which receive electrons from a single 
membrane-bound enzyme, NADPH cytochrome P450 reductase, which contains FAD and FMN 
cofactors (Lewis 1996). The overall reaction of the cytochrome P450 monooxygenase is: 
RH + O2 + NADPH + H
+
 ! ROH + H2O + NADP
+ 
The principal features of the consensus mechanism of cytochrome P450 are the following: 
I. At the beginning of the cycle, the substrate binds to the enzyme, sometimes accompanied by a spin-
state change of the iron, to afford an enzyme-substrate adduct. 
II. This is followed by the reduction of the ferric cytochrome P450 by an associated reductase with an 
NADPH-derived electron to the ferrous cytochrome P450. 
III. Binding of molecular oxygen to the ferrous heme produces a ferrous cytochrome P450-dioxygen 
complex. 
IV. Then, the Fe(III)-hydroperoxy complex is formed by a second one-electron reduction and 
protonation. 
V. Afterwards, protonation and heterolytic cleavage of the O-O bond with concurrent production of a 
water molecule forms a reactive iron-oxo intermediate. 
VI. Finally, the oxygen-atom is transferred from this iron-oxo complex to the bound substrate to form 
the oxygenated product complex. The product dissociation completes the cycle (Groves 2005). 
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Figure 2.2.3: Catalytic mechanism of P450 enzymes. 
P450s are usually monooxygenases, catalyzing the insertion of one of the atoms of molecular oxygen into a 
substrate, the second atom of oxygen being reduced to water. The most frequently catalyzed reaction is 
hydroxylation (O insertion) using the very reactive and electrophilic iron-oxo intermediate (species [C], bottom 
row). The hydroperoxo form of the enzyme (species [B]-) is also an electrophilic oxidant catalyzing OH+ 
insertion. Nucleophilic attack can be catalyzed by species [A]2- and [B]- ; reduction, isomerization or 
dehydration are catalyzed by the oxygen-free forms of the enzyme. This, together with the variety of the 
apoproteins and intrinsic reactivity of all their substrates explains the extraordinary diversity of reactions 
catalyzed by P450 enzymes (Werck-Reichhart and Feyereisen 2000). 
2.3.2 Cytochrome P450 reductase 
NADPH-cytochrome P450 reductase (CPR) is the electron donor protein for several oxygenase 
enzymes found on the endoplasmic reticulum of most eukaryotic cells. CPR is a flavoprotein 
containing four different domains: FMN-binding domain, the connecting domain, the FMN-binding 
domain and the NADPH-binding domain. The FAD domain is the electron acceptor flavin from 
NADPH and the FMN is the electron donor to acceptor proteins such as the cytochromes: 
    Electron flow 
 NADPH  FAD  FMN  Cytochrome P450 
2.3.3 Human cytochrome P450 2B6 
P450 2B6 is expressed primarily in liver. The protein however, has also been detected in lungs. The 
mean level of P450 2B6 in human liver has been controversial,  and can be estimated to 1% of the 
total P450. This value rarely exceeds the 5% even in samples from individuals administered inducers. 
Many reactions have now been demonstrated to be catalyzed by recombinant P450 2B6. However, this 
information must be considered in the context of the amount of P450 2B6 present in liver and 
intestine, particularly in comparison with P450 3A4. One estimate has been made that P450 2B6 is 
involved in ~3% of drug metabolism reactions (Guengerich 2005). This enzyme is involved in the 
metabolism of many drugs such as cyclophosphamide (alkylating antineoplastic agent), propofol 
(anesthetic), tamoxifen (SERM), valproic acid (anticonvulsant , mood-stabilizing), nicotine (stimulant) 
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(Ekins and Wrighton 1999). The list of other substrates includes xenobiotics such as herbicides, 
(acetochlor, esprocarb) (Inui et al. 2001), insecticides (carbaryl, fenitrothion, methoxychlor) (Ekins 
and Wrighton 1999; Inui et al. 2001), and industrial chemicals (nonylphenol and PCBs) (Ariyoshi et 
al. 1995; Lee et al. 1998; Inui et al. 2001). 
2.3.4 Human cytochrome P450 2C19 
Significant expression of P450 2C19 only occurs in liver. This enzyme is a relatively minor P450 in its 
abundance, probably accounting for <5% of total P450. Genetic polymorphism exists for CYP2C19 
expression, with approximately 3–5% of Caucasian and 15–20% of Asian populations being poor 
metabolisers with no CYP2C19 function (Guengerich 2005).  
The list of substrates includes not only drugs but also xenobiotics. It is involved in the metabolism of 
several important groups of drugs including many proton pump inhibitors (e.g. omeprazole, 
pantoprazole) and antiepileptics (e.g. diazepam, phenobarbital). Other substances, which were 
reported as substrate: diclofenac (non steroidal anti-inflammatory drug), Propranolol (beta blocker), 
cyclophosphamide (alkylating antineoplastic agent), indomethacin (non steroidal anti-inflammatory 
drug), nelfinavir (antiretroviral), progesterone (sex hormone), teniposide (chemotherapeutic), warfarin 
(anticoagulant), tetrahydrocannabinol (psychoactive). The list of substrates includes xenobiotic such as 
herbicides (e.g. pyriminobac-methyl, atrazine, simazine, chlortoluron, norflurazon), insecticides 
(carbaryl, methoxychlor), and industrial chemical (nonylphenol) (Inui et al. 2001). 
2.4 Metabolism with cell cultures  
2.4.1 Cytochromes P450 and their role in plant metabolism 
Both in animals and plants cytochrome P450 monooxygenases (P450s, CYPs) are mainly responsible 
for the oxidative primary metabolism of exogenous lipophilic compounds. Regarding man and 
mammals, a number of detailed data are available on the oxidation of pharmaceuticals, xenobiotics 
and pesticides by P450 isozymes (Guengerich 2005). Overexpression of mammalian P450 isozymes in 
higher plants, such as tobacco, was shown to enhance the oxidative metabolism of herbicides and thus, 
generate resistance in the transgenic plants. Similarly, P450-transgenic plant cell suspension cultures 
can be produced and established, which overexpress human P450s; these systems can then be utilised 
to examine the oxidative metabolism of xenobiotics (Kawahigashi et al. 2002; Bode et al. 2004; 
Berger et al. 2005).  
2.4.2 Cytochrome P450 monooxigenase and reductase in Saccharomyces cerevisiae 
Within the yeast Saccharomyces cerevisiae genome, only three CYP genes were found which require 
CPR for function. The first described was CYP51, sterol 14?-demethylase, responsible for the C14-
demethylation of lanosterol (Lamb et al. 1999). This P450, which is constitutively produced at low 
levels in aerobiosis, appears to be specific for C14-sterol demethylation and seems almost or totally 
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inactive towards most xenobiotic compounds (Urban et al. 1994). The second yeast P450 is CYP56, 
expressed only during sporulation and associated with the production of the dityrosines involved in the 
spore wall reticulation (Urban et al. 1994; Lamb et al. 1999). Nothing is known about its substrate 
specificity, but this P450 is absent under the vegetative conditions used for heterologous expression 
(Urban et al. 1994). The third cytochrome P450 is CYP61, sterol 22-desaturase, catalysing C22-
desaturation of ergosta-5,7-dienol (Lamb et al. 1999). This P450 may have some xenobiotic metabolic 
activity such as ethoxyresorufin-O-deethylation and benzo[a]pyrene-hydroxylation reactions. These 
activities are nevertheless undetectable under aerobic conditions in the absence of catabolic repression. 
Yeast cells grown in galactose-containing medium have a very low amount of total endogenous P450s, 
which remain undetectable on the basis of both spectral analysis and the assay of xenobiotic-directed 
activity (Urban et al. 1994). Furthermore, yeast cells contain a moderate level of endogenous P450 
reductase (YCR).  
2.4.3 Yeast as heterologous expression system for cytochrome P450 
Analysis of human xenobiotic metabolism and particularly of drug metabolism is a difficult task due 
to the complexity of Phase I - Phase II coupled biotransformations. Phase I consists of 
functionalization reactions which comprise oxidations, reductions and cleavage reactions that are 
mainly dependent on monooxygenases belonging to the P450 superfamily. Phase II comprises 
conjugation reactions of Phase I products with a variety of hydrophilic molecules such as glutathione, 
glucuronic acid, sulphate, and acetate. These reactions are catalyzed individually by a large number of 
enzyme subtypes. In addition, most of Phase I and II enzymes are concerned by interindividual 
polymorphism of expression and, in some cases, of functionality (Pompon et al. 1997). Traditional 
approaches aimed to identify the involvement of a specific enzyme in the metabolism of a certain 
xenobiotic by immuno-quantification and immunoinhibition techniques. Nevertheless, substrate 
specificity overlaps are frequently found in the P450 “superfamily”. In addition, complex metabolic 
pathways involving a large number of intermediates and sequences of mixed Phase I and II reactions 
occur sometimes (Pompon et al. 1997). Phase II enzymes are, in most cases, naturally absent in S. 
cerevisiae (Urban et al. 1994). The development of efficient molecular tools, making it possible to 
analyze individual bioconversion steps by well-characterized enzymes, appeared rapidly critical for 
valuable toxicological predictions. For these reasons the heterologous expression of CYP P450 species 
in S. cerevisiae is particularly promising for the identification of xenobiotic metabolites. Yeast S. 
cerevisiae offers a low-cost and efficient way to express heterologously P450s. Nevertheless, the 
limited amount of endogenous P450-reductase (YCPR) present in this organism could be a limitation, 
when high specific activities of expressed P450s are required. There are three possible solutions for 
this problem: 
• Construction of artificial gene fusions encoding a chimeric protein composed of a foreign P450 
fused in frame to YCPR. This approach does not allow for the modulation of relative enzyme 
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stoichiometries. In addition the protein engineering required may have some unpredictable 
consequences on P450s function (Pompon et al. 1996); 
• Coexpression of CYP P450 and YCPR systems involving multiple plasmids or multiple 
expression cassettes on single plasmids. This approach can create genetic instability of the strain, 
if many or large plasmids are used (Pompon et al. 1996); 
• Genomic modification for the expression of YCPR (insertion of a galactose regulated promoter 
upstream the YCPR) and CYP P450 overexpressed in a vector under the control of a galactose-
regulated promoter (Pompon et al. 1996).  
2.4.4 Simazine and P450 metabolism 
Simazine belongs to the chlorotriazines herbicides, which comprise e.g. atrazine, and propazine. The 
principal mode of action is to selectivity inhibit plant photosynthesis. These chlorotriazines remain in 
the soil because of low chemical reactivity, which can lead to the contamination of ground and surface 
water. Furthermore, residual amounts of these chlorotriazines and their metabolites have been found in 
drinking water and processing foods (Hanioka et al. 1999). It has been observed that simazine, atrazine 
and propazine increase the incidence of benign or malignant mammary tumors in female Sprague–
Dawley rats. It has been reported that simazine, atrazine and propazine are readily absorbed from the 
gastrointestinal tract in experimental animals and are mainly distributed into the liver and kidney 
(Bakke et al. 1972; Hanioka et al. 1999). Although these chlorotriazines do not structurally resemble 
steroid hormones, it has been suggested that these chlorotriazines alter steroid receptor activity and 
expression in the rats (Eldridge et al., 1994; Stevens et al., 1994; Tennant et al., 1994; Tran et al., 
1996).  
Experiments conducted in resistant corn showed that atrazine was metabolized via both the 2-
hydroxylation and N-dealkylation pathways besides the crucial conjugation with glutathione 
(substitution of the chlorine), while sorghum metabolized atrazine via the N-dalkylation pathway 
(Shimabukuro 1968). 
In vitro metabolisms of simazine, atrazine and propazine by the soluble fraction from goose, pig and 
sheep liver-homogenates proceeded via partial N-dealkylation accompanied by hydrolysis. Hydrolysis 
of simazine to the corresponding hydroxy-analogues seems to be slower than dealkylation (Shahamat 
U. Khan 1979). The dominant metabolic pathway in vivo in rats of simazine, atrazine and propazine is 
N-monodealkylation, isopropylhydroxylation, and to a lower percentage hydroxylation (e.g. 2-
hydroxylation or alkylhydroxylation) (Bakke et al. 1972; Bradway and Moseman 1982; Lang et al. 
1996). . 
In human liver microsomes, the major metabolites of triazine formed are the mono-dealkylated forms: 
desethyl and desisopropyl; hydroxylation of the isopropyl groups present in atrazine and propazine 
also occurs, but to a lesser extent. Other metabolites formed in vivo and found in human urine are the 
fully dealkylated metabolite of the triazines (atrazine-desethyldesisopropyl) and several 2-
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hydroxylated metabolites. Triazine metabolism is catalyzed primarily by cytochrome P450 (CYP) 
enzymes (Bradway and Moseman 1982; Adams et al. 1990; Sanderson et al. 2001). 
2.4.5 Methoxychlor and P450 metabolism 
Methoxychlor is a biodegradable insecticidally active pesticide and a substitute for the banned DDT 
(Hu and Kupfer 2002). It is a contact insecticide and also has stomach action (Di Terence and Hutson 
1998). The solubility in water of this pesticide is 0.1 mg/l and the LogKow is 4.83 (Di Terence and 
Hutson 1998).  
Methoxychlor has a relatively low toxicity and short half-life (Hu and Kupfer 2002); despite these 
favorable features of methoxychlor, there is considerable concern for exposure to methoxychlor 
because of its estrogenic activity; in vivo methoxychlor exhibits pronounced estrogenic activity, 
indicating that methoxychlor per se is a proestrogen (Hu and Kupfer 2002). Methoxychlor undergoes 
oxidative metabolism by hepatic cytochrome P450 forming metabolites with pronounced estrogenic 
activity (Bulger et al. 1978; Bulger et al. 1978; Hu and Kupfer 2002). However, hitherto it has not 
been established whether the endocrine and reproductive toxicities are associated with methoxychlor 
per se or are primarily due to its metabolites. Interestingly, the mono- and bis-demethylated 
methoxychlor metabolites (mono-OH-M and bis-OH-M) exhibit opposing activities toward the ER! 
and ER" isoforms [i.e., both metabolites are agonists of ER!, but antagonists of ER", as well as 
antagonists of the androgen receptor] (Hu and Kupfer 2002).  
It has been known for some time that methoxychlor is O-demethylated to the mono-OH-M and bis-
OH-M, followed by ortho-hydroxylation to form the tris-OH-M (Kupfer et al. 1990; Dehal and Kupfer 
1994; Stresser and Kupfer 1997). 
Generally, cDNA-expressed P450s displayed catalytic activities as demethylases and/or hydroxylases. 
Interestingly, CYP2C19 was the only P450 that demonstrated relatively high activity in all three O-
demethylation reactions involving both methoxychlor and its metabolites, indicating a lack of 
fastidious substrate specificity for 2C19. The catalytic potency of the P450-mediated O-demethylase 
activities of methoxychlor was in the order of CYP2C19 >1A2, 2C9 > 2A6, 2B6, 2C8, 2D6 > 1A1, 
3A4, 3A5, rat 2B1. The catalytic activity of ortho-hydroxylase was in the order of CYP3A4 > 2B6, 
3A5. However, CYP1B1, 2E1, and 4A11 were essentially inert in both reactions. In contrast, 2B6 
demonstrated remarkable dual catalytic activities, involving O-demethylation and ortho-hydroxylation 
(Hu and Kupfer 2002). 
2.5 Methods for disinfection of WWTP and DWTP: chlorination 
2.5.1 Chemical disinfection 
Chemical disinfection is carried out to kill or control the microorganisms in water which can adversely 
affect its quality, cause fouling or corrosion of equipment, or lead to disease from microbial activity 
(Hooper 1987). The purpose of disinfection of potable water is to destroy pathogenic organisms and 
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thereby eliminate and prevent waterborne diseases (White 1972). The chemicals used as antimicrobial 
agents in water treatment can be split into two broad groups: oxidizing and not-oxidizing agents. 
Oxidizing biocides include chlorine, chloramines, chlorine dioxide, ozone, bromine, bromamines and 
certain organic bromining-containing compounds. Non oxidizing biocides include chemicals such as 
formaldehyde, iso-thiazalones, iso-thiocyanates, bromopropionamides, quaternaryammonium 
compounds, chlorinated phenols, organo-sulphur compounds. Chlorine is one of the cheapest, safest, 
easiest, and most widely used chemicals in the control of microbial agents (Hooper 1987). 
2.5.2 Chlorination in drinking water and wastewater 
Chlorine is used either as gaseous chlorine or a hypochlorite salt (usually sodium). The gas can either 
be injected directly or generated in situ by electrolysis techniques, but in all cases it is the production 
of HOCl which s the key agent in disinfection: 
Cl2 + H2O ! HOCl +HCl 
and 
NaOCl + H2O ! HOCl + NaOH 
A further reaction also occurs: 
HOCl ! H
+
 + OCl
- 
The extent of these reactions to take place depends on the pH of the water (Hooper 1987). 
 
Figure 2.2.4: Schematic simplified representation of WWTP 
Preliminary treatment (not shown). The velocity of the wastewater from the sewer lines is reduced as it enters 
the treatment plant. This allows sand, gravel and other heavy materials to settle out into grit tanks. Mechanical 
cleaning bar screens then remove rags, sticks, plastic and other foreign objects from the wastewater. Bar screens 
may be used before or after the grit tanks. Primary treatment allows for the physical separation of solids and 
grease from the wastewater, and removes between 30-40 percent of the biological oxygene demand (BOD) and 
50 per cent of the total suspended solids (TSS). The settled particles are known as primary sludge, which is 
collected and pumped to large digestion or holding tanks for further treatment and solids processing. Secondary 
treatment is a biological treatment process that removes up to 90 percent of BOD and TSS. Following primary 
treatment, effluent is pumped to the secondary treatment stage. The growth of microorgisms results from the 
consumption of organic matter in the wastewater as their food supply. The micro-organisms create a solid 
organic material (sludge), which is just like the sludge from primary treatment. Secondary sludge is thickened 
and pumped to digesters for processing and solids processing. Final treatment. To kill harmful microorganisms 
several disinfection methods can be used. One of them is the chlorination treatment, before reintroducing the 
water in the environment (Karr 2007). 
The chemistry of the chlorination of potable water (DWTP) and wastewater (WWTP) is 
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fundamentally the same. The reactions differ only because of the differences in species and amounts of 
interfering substances, both organic and inorganic (White 1972).  
All forms of chlorine are widely used despite their respective drawbacks. One drawback is that 
chlorine from any source reacts with natural organic compounds in the water to form potentially 
harmful chemical by-products trihalomethanes (THMs) and haloacetic acids (HAAs), both of which 
are carcinogenic in large quantities (Lee et al. 2004).  
In wastewater treatment plants (WWTP) the most important points of chlorine application are: 
prechlorination for odor control and postchlorinaton for disinfection (White 1972) (see Fig. 2.4 ). 
In Fig. 2.5 is reported a schematic description of the DWTP process. Likewise the WWTP the chlorine 
is added for odour control and for disinfection purposes. 
 
Figure 2.2.5: Scheme of DWTP 
(1) Raw water is pumped to water treatment plant and (2) enters through the headworks facility, where non-toxic 
chemicals are added to make solid particles clump together and improve taste and odor. (3) Water is then 
pumped to a sedimentation basin, which allows time for solids to settle. (4) As water is pumped to filters, a 
liquid form of chlorine is added for initial disinfection. (5) Water flows downward through filters, where 
additional particles are removed. (6) The water enters the post-filtration stage, where the pH (acidity/alkalinity) 
is set at the right level. The water then flows to the clearwell (7) for temporary storage. Chlorine is added to 
disinfect the water. The water is pumped daily to one of several elevated storage tanks (8), which provide 
pressure so finished water can be delivered to the tap through network of water lines (OWASA 2004). 
2.5.3 Chlorination of nonylphenol 
Chlorination is an essential treatment unit of the water supply system and, in many countries, is used 
in waste water treatment plants (WWTP) as disinfection process. The capacity of phenolic compounds 
to react with hypochlorite is well known. Chlorinated derivatives of 4-NP have been detected in 
WWTP effluent and drinking water treatment plants (DWTP) (Petrovic et al. 2001; Petrovic et al. 
2003). Contrasting data concerning the estrogenic activity of the aqueous chlorinated 4-NP mixtures 
have been described in literature. One study reported that the aqueous chlorinated 4-NP mixtures elicit 
antiestrogenic activities (Hu et al. 2002); another study showed that chlorination is an efficient method 
to eliminate the estrogenic activity of 4-NP (Lee et al. 2004). Furthermore, the mono and di-
chlorinated derivatives of p-NP isomers mixture showed less estrogenic activity than the parent 
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compounds (Kuruto-Niwa et al. 2005). Because the isomeric composition of 4-NP differs among 
producers and additionally the environmental processes can lead to a shift in the isomeric composition 
of NP, it is necessary to assess the estrogenic potency of individual isomers in order to improve the 
environmental risk assessment (Preuss et al. 2006). So far, no attention has been paid to the estrogenic 
potency of pure para mono-chlorinated (p-MClNP) and di-chlorinated (p-DClNP) derivatives of 
different NP isomers. Finally, the oxidation by-products generated during the chlorination treatment 
must be taken in account and their estrogenic potencies must be assessed. 
In a German Ph.D. thesis, the introduction usually ends with the aims or tasks of the Ph.D. thesis 
(subheading: Aims). You should summariz e here the things you already mentioned in the text before. 
This has to be written in a form which includes many 'should' or something like that. It is meant as the 
starting point of your practical work which follows in the text. It is not necessary to give some 
chronologically correct version of your entire work but some idealized version. Simply list here what 
you did in a form indicating that it should be done. 
2.6 Task of this work 
The task of this study would be to get more information about the behaviour and the effect of 
nonylphenol isomers and some of their derivatives. The aims have been divided in the two main parts 
that will be described below. 
2.6.1 Part A: metabolism studies of nonylphenol 
Two genes cyp2b6 and cyp2c19, as reported in literature, are able to metabolize nonylphenol. These 
two enzymes should be used to transform the yeast Saccharomyces cerevisiae. The transformation 
would be performed in two different ways: 
• System 1: the YR and the cytochrome P450 monooxigenase would be inserted in one plasmid 
under the control of a strong promoter galactose-inducible. The vector would be used to transform 
the yeast and in this way the two genes would be over-expressed. 
• System 2: the YR would be regulated at a genomic level in the yeast under the control of a strong 
promoter galactose-inducible (system obtained from Dr Pompon, France). The cytochrome P450 
monooxigenase would be inserted in a vector and this construct would be used to transform the 
yeast. In this way only the cytochrome P450 monooxigenase is over-expressed. 
The expression of the cytochrome P450 monooxygenase would be verified for both systems using two 
radioactive substrates: simazine (substrate of cyp2c19) and methoxychlor (substrate of cyp2b6). Once 
verified the functionality of the proteins the two systems would be used for metabolism studies of 
branched nonylphenol in order to identify nonylphenol metabolites.  
The branched nonylphenol would be synthesized, as 
12
C, 
13
C and 
14
C and the final analysis would be 
performed using an equimolar concentration of 
12
C/
13
C nonylphenol by the mean of GC/MS. In this 
way it would be easy to identify the metabolites marked by the characteristic double peak in the mass 
spectra.  
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2.6.2 Part B: estrogenic and androgenic potency of branched nonylphenol isomers and 
their derivatives 
Different nonylphenol isomers, as reported in literature, show different estrogenic activity. Therefore 
derivatives of nonylphenol may present different estrogenic potency. 
The first aim would be the synthesis of mono and di-chlorinated derivatives of four branched 
nonylphenol isomers. Once purified and verified the structure by GC/MS and NMR their estrogenic 
and androgenic potency would be assessed using the YES and YAS assay. These tests would assess if 
the addition of one or two chlorine on the phenol ring would increase or decrease the xeno-hormone 
potency of nonylphenol.  
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3 Materials and methods 
3.1 Organisms 
3.1.1 Bacteria 
Escherichia coli strain DH5! . F
-
, #80lacZ!M15, !(lacZYA-argF), U169, recA1, endA1, hsdR17(rk
-
, mk
+
), phoA, supE44, $
-
, thi-1, gyrA96, relA1F
-
. This bacterial strain possessed a modified 
recombination system (recA1), which resulted in reduced recombination probability, and lacked 
endonuclease (endA1). It was therefore used in the cloning experiments (Invitrogen, Germany) 
3.1.2 Yeast strains (Saccharomyces cerevisiae) 
YPH499 Yeast Strain. Mat !, ura3–52, lys2–801
amber
, ade2–101
ochre
, trp1–"63, his3–"200, leu2–"1. 
It was unable to grow on minimal media lacking one of these nutrients (uracil, lysine, adenine, 
tryptophane, histidine, leucine), unless the corresponding gene is introduced by transformation or 
mating. (Stratagene, Germany). 
W(YR) Yeast Strain. Obtained from Dr. Denis Pompon, France. The strain W303.1B (Mat a, ade2-1, 
his3-11, 15, leu2-3, 112, ura3-1, trp1-1, can
R
, cyr
+
) was constructed by R. Rothstein. W(YR) came 
from the stable integration, into the genome of W303.1B, of the galactose-inducible GAL10-CYC1 
promoter coding sequence at the 5’ end of the yeast NADPH-P-450 reductase-encoding gene open 
reading frame (Truan et al. 1993).  
YES cells. Obtained from Prof. Sumpter, UK. The recombinant yeast strain was developed in the 
Genetic Department at Glaxo. The human Estrogen Receptor (hER) was stably integrated into the 
main chromosome of the yeast. The yeast cells also contained expression plasmids carrying the 
reporter gene lac-Z (encoding the enzyme b-galactosidase), which was used to measure the receptors’ 
activity (Routledge and Sumpter 1996). 
YAS cells. Obtained from Prof. Sumpter, UK. The recombiant yeast was constructed as the YES cells, 
but with the human Androgenic Receptor (hAR) (Sohoni and Sumpter 1998). 
3.2 Plasmids 
3.2.1 pESC-URA, pESC-TRP 
Commercially available vectors (Stratagene, Germany). These vectors contained the GAL1 and GAL10 
yeast promoters in opposing orientation. With these vectors, one or two cloned genes could be 
introduced into a yeast host strain under the control of a repressible promoter.  
Each vector contained an auxotrophic selectable marker gene (URA3, TRP1). The complete sequences 
for the vectors were available from www.stratagene.com and from the GenBank® database (pESC-
TRP:Accession #AF063848, pESC-URA: Accession #AF063585). 
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3.2.2 pYeDP60 
Vector obtained from Dr. Philippe Pompon, France. This was a shuttle vector for yeast expression. 
The vector contained a galactose-inducible GAL10-CYC1 promoter and had two auxotrophic 
selectable markers, ADE2 and URA3. 
3.2.3 pCW’2b6 and pCW’2c19 
Vectors obtained from Elizabeth Gillam, Faculty of Biological and Chemical Sciences, The University 
of Queensland, Australia. They were bacterial expression vectors containing the genes (cDNA) of 
cytochrome P450 monooxygenases CYP2B6 and CYP2C19. 
3.3 Yeast cells culture 
3.3.1 pT2b6 and pT2c19 
The gene yeast reductase (YR) was inserted in both vectors pESC-URA and pESC-TRP. Afterwards, 
the gene (cDNA) cyp2b6 was inserted in the vector pESC-TRP, and the gene (cDNA) cyp2c19 was 
inserted in the vector pESC-URA. These vector were used to transform the yeast Saccharomyces 
cerevisiae strain YPH499 to obtain the yeast cells cultures pT2b6 and pT2c19, respectively. 
3.3.2 PY2b6 and PY2c19 
The genes (cDNA) cyp2b6 and cyp2c19 were separately inserted in the vector pYeDP60. The resulting 
vectors were used to transform the yeast Saccharomyces cerevisiae strain W(YR) to obtain the yeast 
cells cultures PY2b6 and PY2c19, respectively. 
3.4 Culture media and plates 
All the media were autoclaved for at 121 °C for 15’. 
3.4.1 LB and LBA media 
This media was used for cultures of bacteria. 
 
Components Final concentration 
Yeast extract (Fluka) 5 g/l 
Trypticase Peptone (Roth) 10 g/l 
NaCl (Roth) 10 g/l 
H2O To volume 
For plates Agar (Sigma) 10 g/l 
 
For LBA medium add Ampicillin (Sigma) to a final concentration of 100 mg/l after autoclaving. 
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3.4.2 YAPD media 
This media was used for cultures of yeast, pT2b6/pT2c19 and PY2b6/PY2c19. 
 
Components Quantity 
l-adenine hemisulfate salt (Sigma) 0.0075% 
Bacto Peptone (BD) 2% 
Yeast extract (Fluka) 1% 
Glucose (BD) 2% 
For plates Agar (Sigma) 1% 
H2O To volume 
3.4.3 YEPD media 
The media was used for PY2b6/PY2c19 yeast cells cultures. 
 
Components Quantity 
Bacto Peptone (BD) 10 g/l 
Yeast extract (Roth) 10 g/l 
EtOH 30 ml/l 
Glucose (Fluka) 5 g/l 
For plates Agar (BD) 17 g/l 
H2O To volume 
3.4.4 SW(6) media 
This was a minimal media used for PY2b6/PY2c19 yeast cells cultures. 
 
Components Final concentration 
Yeast nitrogen base (Difco) 7 g/l 
Casamino acid (Difco) 1 g/l 
Trypthophan (Sigma) 20 mg/l 
Glucose (Fluka) 20 g/l 
For plates Agar (Sigma) 15 g/l 
H2O To volume 
3.4.5 N3 media 
In modified yeast strains expressing yeast reductase only after induction (YR), the YR deficiency 
provokes a significant instability of the yeast mitochondrial genome, which frequently leads to slow 
growing clones unable to use galactose as a carbon source in minimal medium. This can be avoided by 
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checking transformants for growth on glycerol containing N3 medium (Pompon et al. 1996). 
 
Components Quantity 
Bacto Peptone (BD) 10 g/l 
Yeast extract (Roth) 10 g/l  
Glycerol (Sigma) 20 ml/l 
For plates Agar (Sigma) 17 g/l  
H2O To 1 l volume 
3.4.6 SD and SG media 
This was a minimal media for yeast cultures. 
 
Components Quantity 
Yeast nitrogen base without amino acids (Fluka) 0.67 g/l 
Glucose  (Fluka) 20 g/l  
Amino acid dropout powder (see below for preparation) 1.3 g/l 
For plates BactoAgar (Sigma) 20 g/l  
H2O To 1 l volume 
 
The SG media contained galactose instead of glucose. 
The amino acids (Sigma) listed in the following table were combined in solid form, mixed, and then 
added to the liquid growth media. The solid compounds were grinded into a homogeneous mixture 
with a clean, dry mortar and pestle. This mixture was stored in a clean, dry bottle at room temperature. 
To select for transformed cells, the amino acid for which the plasmid contained a marker gene 
essential for biosynthesis of the amino acid was left out. 
 
Amino acids Quantity in drop out powder (g) 
Adenine sulfate 2.5 
L-arginine (HCl) 1.2 
L-aspartic acid 6.0 
L-glutamic acid 6.0 
L-histidine 1.2 
L-leucine 3.6 
L-lysine 1.8 
L-methionine 1.2 
L-phenylalanine 3.0 
L-serine 22.5 
L-threonine 12.0 
  3. Materials and methods 
- 25 - 
L-tryptophana 2.4 
L-tyrosine 1.8 
L-valine 9.0 
Uracil 1.2 
 
3.5 Microbiological methods 
3.5.1 E. coli culture 
E. coli was cultured in LB medium on a horizontal shaker at 37°C and 210 rpm, or on LB agar plates 
at 37°C over night (o.n.). 
3.5.2 Competent cells of E. coli 
• Start was from a single colony with the o.n. culture in 5 mL of LB at 37°C.  
• The 100 mL LB were inoculated with the o.n. culture and the culture was grown at 37°C until the 
OD600 reached 0.25-0.5.  
• The cultures were then precooled in 4 Falcon tubes 50 ml (Greiner Bio-one). 
• Bacteria were harvested at 4°C in the Falcon tubes by centrifugation (4°C, 3.000 rpm, for 5 min; 
Hettich). 
• The bacterial pellet was resuspended in 7.5 ml of ice cold TFB1 medium sterilized by filtration. 
• The bacteria were kept on ice for 10 min. 
• Then, bacteria were harvested by centrifugation (3000 rpm, for 10 min at 4°C; Hettich). 
• The bacterial pellet was resuspended in 1 ml of ice cold TFB2 medium sterilized by filtration. 
• The bacteria were kept on ice for 5 min. 
• Aliquots of 100 !L were transfered into sterile tubes, and were immediately frozeen in liquid 
nitrogen. 
• Stocks of the competent cells were stored at –80°C. 
 
TFB1 
Components Concentrations  Quantity (g) 
KOAc (Fluka) 30 mM 0.147 g 
RbCl (Sigma) 100 mM 0.602 g 
CaCl2 (2xH2O) (Sigma) 50 mM 0.056 g 
MnCl (4xH2O) (Merck) 50 mM 0.495 g 
Glycerol (Sigma) 15% 7.5 ml 
H2O  To 50 ml 
 
The pH was adjusted to 5.8 with acetic acid, and the resulting medium was sterilized by filtration. 
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TFB2 
Compounds Concentrations Quantity 
MOPS (Sigma) 10 mM 0.105 g 
CaCl2 (Sigma) 75 mM 0.416 g 
RbCl (Sigma) 10 mM 0.061 g 
Glycerol (Sigma) 15% 7.5 ml 
H2O  50 ml 
 
The pH was adjusted to 6.5 with KOH solution and sterilized by filtration. 
3.5.3 Transformation of competent cells of DH5! E. coli 
The competent bacteria were thawed on ice. 
• After 10-15 min 100 µl of the suspension of the competent cells were supplemented with 10 µl of 
the solution of the vectors resulting from the ligation reaction; 
• The mixture was kept on ice for 20 min; 
• Then, the mixture was heated to 42°C for 2 min (heat shock); 
• The mixture was kept on ice for 5 min; 
• Then, 0.9 ml of LB medium were added; 
• The mixture was kept for 1 h at 37°C (no shaking); 
• It was subsequently centrifuged (Heraeus) at 3000 rpm for 5 min; 
• After separation, the pelleted cells were resuspended in 100 µl of LB medium; 
• the mixture was put on LBA plates (2 plates, dilution 1:10 and 9:10); 
• the plates were incubated o.n. at 37°C. 
3.5.4 Preparation of yeast competent cells 
• An o.n. yeast culture was diluted 1:20 with 50 ml YPAD broth to an OD600 of 0.25 (suitable for 
10 transformation procedures). 
• The culture was incubated at 30 °C for approximately 4-5 h until it reached an OD600 of 1.0. 
• The cells were separated by centrifugation at 1000 x g for 5 min. The supernatant was discarded. 
• Then, the cells were re-suspended in 10 ml of LTE buffer. 
• This suspension was centrifuged at 1000 x g for 5 min, and the supernatant was discarded. 
• The cells were re-suspended in 0.5 ml of LTE buffer. This cell suspension could be stored at 4 °C 
for up to 3 days. 
• An aliquot of 50 µl of the cell suspension was transferred into microcentrifuge tubes. 
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LTE 
Components Concentration 
LiOAc (Roth) 0.1 M 
Tris-HCl (pH 7.5) (Applichem) 10 mM 
EDTA (Sigma) 1 mM 
3.5.5 Transformation of whole yeast cells 
The transformation mix and the plates lacking specific amino acid were prepared prior to the 
beginning of the transformation of the whole yeast cells. 
• The respective plasmid or its derivatives (1-3 µg) were added to the yeast cell suspension. 
• Then, the transformation mix (300 µl) was added to each tube, which was invert for proper 
mixing. 
• The tubes were incubated at 30 °C for 30 min. 
• Subsequently, the tubes were heat at 42 °C for 15 min. 
• The transformation reaction mixture (100 µl and 250 µl) were plated onto two appropriate amino 
acid lacking plates with dextrose (D-glucose) as the carbon source. The plates were incubated at 
30 °C for 2-3 days. 
 
Transformation mix 
Components Concentration 
Polyethylene glycol 3350 (PEG 3350) (Fluka) 40% 
LiOAc (Roth) 0.1 M 
Tris-HCl (pH 7.5) (Applichem) 10 mM 
EDTA (Sigma) 1 mM 
 
3.6 Molecular and biochemical methods 
3.6.1 Isolation of plasmids DNA 
Plasmid mini prep kits (Qiagen) were used to isolate plasmid DNA from transformed DH5! 
(competent E. coli strain) transformed with different constructs according to the instructions provided 
with these kits. For verification of quality and quantity, 2-5 µl of the total DNA eluate was digested 
with the proper restriction enzyme and visualized on a 1% (w/v) agarose gel containing ethidium 
bromide (Fluka). 
3.6.2 Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) performed with Mastercycler gradient (Eppendorf) is a method for 
enzymatic amplification and modification of a target DNA sequence flanked by two known sequences. 
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Below, an example of a PCR reaction is reported based on the quantity of each reagent in 20 µl of total 
reaction volume. However, the reaction volume was occasionally scaled up or down. 
 
Primer 
forward 
10µM 
(Metabion) 
Primer 
reverse 
10µM 
(Metabion) 
DNA 
template 
MgCl2 
50mM 
(Invitrogen) 
Buffer 
polymerase 
5X 
(Invitrogen) 
dNTPs 
2mM 
(Fermentas) 
DNA 
polymerase 
(Invitrogen) 
H2O 
1µl 1µl 2µl 0.6µl 4µl  2µl 0.2µl 9.2 
 
The amplification of genes (used for cloning) has been performed using a Reading I-Proof High 
Fidelity DNA Polymerase (Bio-Rad), and the annealing temperature for the primers was calculated as: 
Ta=Tm-3°C, where the Tm was the lowest temperature of the pair of primers to be used. The program 
used for amplification was as described in Table 3.1. 
Table 3.1: Typical thermal cycling protocol for i-proof high fidelity DNA polymerase 
 
Cycle step Temperature Time Number of cycles 
Initial denaturation 98°C 30 sec. 1 
Denaturation 98°C 10 sec.  
Annealing Ta 30 sec. 35 
Extension 72°C 60 sec.  
Final extension 72°C 10 min. 1 
 
All other PCR reactions have been performed with the Taq polymerase (Invitrogen) using the as 
annealing temperature Ta=Tm+3°C. The denaturation steps were performed at 95°C. 
3.6.3 Restriction enzyme digestion 
Digestion and double digestion reactions of DNA were performed according to the manufacturer’s 
instructions (Fermentas) and the suggestion on the Fermentas website (www.fermentas.com). 
3.6.4 Colony PCR 
The colony PCR was performed as followed: 
 
Buffer 
DNA 
polymerase 
10X 
Primer 
forward 
10µM 
Primer 
reverse 
10µM 
Tween 20 
10% 
MgCl2 
50mM 
dNTPs 
2mM 
DNA 
polymerase 
H2O 
2 µl 0.3 µl 0.3 µl 0.2 µl 0.6 µl 2.5 µl 0.2 µl 13.9 µl 
 
A transformed colony was picked with a sterile toothpick, and the cells were swirled from the colony 
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to the amplification reaction mixture. Then, the toothpick was removed and put it into a sterile tube 
containing 5ml of LBA medium, and the tube was incubated o.n. at 37°C. 
PCR was subsequently performed using the cycling parameters in Table 3.2. 
Table 3.2: Program for colony PCR 
 
Number of cycles Temperature Length of time 
94°C 4’ 
50°C 2’ 
1 cycles 
72°C 2’ 
94°C 1’ 
56°C 2’ 
30 cycles 
72°C 1’ 
1 cycles 72°C 1’ 
3.6.5 Primers for PCR 
In Table 3.3 all the primers used for the cloning procedures are displayed. 
Table 3.3: Name, sequence, melting temperature, restriction site and vector of destination of the primers. 
 
Name Sequence (5’-3’) Restr. site  Tm(°C) Vector 
YR for AAAGGGCC^CATG CCGTTTGGAATAGACAAC ApaI 68.1 pESC-TRP 
YR rev CCCCCG^TCGACCCAGACATCTTCTTGG SalI 71 pESC-TRP 
YR URA for CACAAGTCGA^CTGCCGTTTGGAATAGACAAC SalI 68.2 pESC-URA 
YR URA rev CGCGCA^AGCTTTTACCAGACATCTTCTTGG HindIII 68.1 pESC-URA 
cyp2b6for GCGCGA^CTAGTATGGAACTCAGCGTCCTCC SpeI 68.3 pCW’ 
cyp2b6rev ATTATA^GATCTTCAGCGGGGCAGGAAGCG BglII 69.5 pCW’ 
cyp2c19for TACCAA^CTAGTATGGATCCTTTTGTGGTCC SpeI 66.9 pCW’ 
cyp2c19rev CTTTCA^GATCTTCAGACAGGAATGAA BglII 66.9 pCW’ 
2b6forint TCATGGACCCCACCTTCCT - 58.8 All 
2b6revint ATGAAGCTCTGGAGGGCGAT - 59.4 All 
2b6forext GTGTGGAATTGTGAGCGGAT - 57.3 pCW’ 
2b6revext ACGTGGGAGTCAGCCATATT - 57.3 pCW’ 
2c19forint TGCAATGTGATCTGCTCCA - 54.5 All 
2c19revint TCTGTGTAGGGCATGTGGC - 58.8 All 
2c19forext GAGCGGATAACAATTTCACACAGG - 61.0 pCW’ 
2c19revext GGAGTCAGCCATATTTATATCTCCT - 59.7 pCW’ 
GAL1for ATTTTCGGTTTGTATTACTTC - 50.1 pESC-
URA/TRP 
GAL1rev GTTCTTAATACTAACATAACT - 48.1 pESC-
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URA/TRP 
GAL10for GGTGGTAATGCCATGTAATATG - 56.5 pESC-
URA/TRP 
GAL10rev GGCAAGGTAGACAAGCCGACAAC - 64.2 pESC-
URA/TRP 
2b6pYeDPfor GCGCGG^GATCCATGGCTCTGTTATTAGCAG BamHI 75 pCW’ 
2b6pYeDPrev ATTATGGTAC^CTCAGCGGGGCAGGAAGCG KpnI 75 pCW’ 
2c19pYeDPfor TACCAGGTAC^CATGGCTCGACAATCTTCTGG KpnI 74 pCW’ 
2c19pYeDPrev CTTTCGAGCT^CTCAGACAGGAATGAAGCACAG SacI 74 pCW’ 
3.6.6 Isolation and purification of DNA fragments from agarose gel 
To isolate DNA fragments (70 bp - 10 kb) from agarose gels, the Invitrogen gel extraction kit was 
employed according to the manufacturer’s instruction. 
3.6.7 Ligation reaction 
Joining linear DNA fragments together with covalent bonds is called ligation. More specifically, DNA 
ligation involves creating a phosphodiester bond between the 3' hydroxyl of one nucleotide and the 5' 
phosphate of another. 
The enzyme used to ligate DNA fragments is T4 DNA ligase (Fermentas), which originates from the 
T4 bacteriophage. This enzyme will ligate DNA fragments having overhanging or blunt end. The 
ligation reaction was set up according to manufacturer’s instructions. 
3.6.8 Agarose gel electrophoresis 
Agarose gel electrophoresis is used in molecular biology to separate DNA or RNA molecules by size. 
This is achieved by moving negatively charged nucleic acid molecules through an agarose matrix 
using an electric field (electrophoresis). Shorter molecules move faster and migrate farther than longer 
ones. The main application of this technique is: 
• Estimation of the size of DNA molecules following restriction enzyme digestion; 
• Analysis of PCR products. 
In the present study, the percentage of agarose used for all gels was 1% (w/v) containing ethidium 
bromide (Fluka). The run was performed in TAE buffer 1X. 
 
TAE 50 X  
Components Quantity 
Tris base 242 g 
Acetic acid 57.1 ml 
EDTA 0.5 M 100 ml 
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The reference ladder used for estimating the size and the quantity of examined DNA are reported in 
Fig. 3.1. 
 
A  B  C 
Figure 3.1: DNA ladders and markers for gel electrophoresis. 
A: GeneRuler 1kb DNA Ladder Plus, used for DNA quantification; B: GeneRuler 1kb DNA Ladder, and C: 
Lambda DNA/HindIII, Marker 2, used for estimating the size of the DNA. 
3.6.9 Sequencing of DNA  
Sequencing reactions were performed by the Institute Fraunhofer, RWTH Aachen. Primers utilized 
(20 pmol) were added to 1.2-1.5 !g of plasmid DNA, and the sequencing reactions were performed 
using the di-desoxy chain termination method with labeled nucleotides and a cycle sequencing 
protocol (Sanger et al. 1977). 
The sequencing results have been analyzed and compared by Vector NTI® software (Invitrogen). 
3.6.10 Yeast protein extraction 
The yeast cells were plated on selective media and incubated o.n at 28°C. One colony was used to 
inoculate 20 ml of minimal media (pre-culture), and 1 ml of the pre-culture was used to inoculate 50 
ml of the subsequent culture that was kept o.n. at 28°C. Then, galactose was added (5 ml of a solution 
20%), and the culture was kept for 72 h at 28°C. For the different yeast cultures (pT2b6/pT2c19 or 
PY2b6/PY2c19) the corresponding media were used.  
Then the following protocol was performed: 
• The yeast cells were harvested by centrifugation (10 min at 5000 rpm); 
• The cells were resuspended in Rothy Load Buffer 4X (Roth); 
• Then, the suspension was boiled in a heating block (Eppendorf) for 2 min; 
• Glass beads (0.5 µm, Roth) were added and the mixture was subjected to a vortex for up to 1 min; 
• The mixture was agaun boiled for 2 min; 
3. Materials and methods   
 - 32 -  
• And vortexed for another 1 min; 
• The mixture was subjected to centrifugation at 13000 rpm; 
• The resulting surnatant was transfered to a fresh tube; 
• Protein was stored at -20°C. 
3.6.11 SDS-PAGE 
The concentrations of all compounds for preparing stacking and separating gel are reported in Table 
3.4. 
Table 3.4: SDS-PAGE gel preparation. 
Quantity of each compound for stacking (5%) and separating gel (12%). The quantity is sufficient for 1 mini-gel 
10X15. 
Compound Stacking Separating 12% 
H2O 2.2ml 1.2ml 
30% Acrilamide-Mix (Roth) 0.5ml 2.0ml 
1M Tris pH 6.8 (Roth) 0.4ml - 
1M Tris pH 8.8 (Roth) - 1.9ml 
10% SDS (Fluka) 30µl 50µl 
TEMED (Roth) 4.5µl 5µl 
 
• The protein samples and the positive control, microsomes with expressed CYP2B6 and CYP2C19 
( ), were boiled for 5 min for denaturation. 
• The samples were chilled on ice and centrifuged for 5 s. 
• The supernatant was harvested as desired protein sample. 
• These samples (from yeast cells and the positive control) and the Pageruler Plus Prestained Protein 
Ladder (see Fig. 3.2) (Fermentas) were loaded into submerged wells. 
The SDS-PAGE gel was run using 1 x SDS-PGAE electrophoresis buffer for 120 min at 120 V/cm. 
The samples were run at 20mA in the stacking gel and at 35mA in the separating gel in SDS-PAGE 
buffer 1X. 
 
10X SDS-PAGE buffer 
Components Concentration 
Tris 250 mM 
Glycin 1.9 M 
SDS 1% (w/v) 
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Figure 3.2: Protein Ladder (Fermentas) for SDS-PAGE and western blot. 
3.6.12 Western blot: semi-dry blotting 
• The separating gel was removed. 
• Two blotting papers (Schleicher & Schuell), the nitrocellulose membrane (Protran B 83-
membrane) and sponges were wetted in the blotting buffer. 
• The wet paper was placed on the anode (+) of the electro blotting apparatus (Fastblot B33). 
• The nitrocellulose membrane was placed on the paper. 
• On the nitrocellulose membrane, the gel and then the other Whatman paper were placed. 
• Air bubbles were removed by rolling a pipette on paper an membrane. 
• The electro blotting apparatus was closed 
• The gel was blotted for 16 min at 90mA. 
• Afterwards, the membrane was washed with bidistilled H2O. 
•  The membrane was transfered to 10ml of TTBS with 5% of BSA for 2 h to block the membrane. 
• Subsequently, the membrane was washed three times with TTBS, each time for 10 min. 
• The primary (specific) antibody (0,2-0,5 !l), for CYP2B6 or CYP2C19 (Virion), was added to 
TTBS buffer supplemented with 5% of BSA, and the assay was incubated it for 2 h at RT or 
overnight at 4°C on a rocking platform. 
• The membranes were washed three times with TTBS, each time for 10 min. 
• Then, the membrane was placed in 10 ml of TTBS supplemented with 5% of BSA, and the 
secondary antibody-conjugate (HRP = horseradish peroxidase), in this case anti rabbit IgG 
peroxidase (Amersham Bioscience), was added, and the assay was incubated for 30 min. 
• The membrane was washed three times with TTBS, each time for 10 min. 
• In a dark room, 500µl of ECL-1 and 500!l ECL-2 solution with 0.5µl of H2O2 30% were added to 
the membrane. 
• The photographic film (Amersham Bioscience) was placed on the membrane for 1 min. 
• Finally, the film was developed using Kodak GBX developer solution (Sigma) and Kodak GBX 
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fixer solution (Sigma). 
 
Blotting buffer SDS-PAGE buffer 1X : H2O 1:2 
 
TBS 10X 
Components Quantity 
Tris-base 30g/l 
KCl 2g/l 
NaCl 80g/l 
 
TTBS 1X 0.05% of Tween 20 (Sigma) in 1X TBS 
3.7 Chemical 
3.7.1 Reference substances 
• Simazine     Riedel-de-Haen, Germany 
IUPAC name: 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 
• N-deisopropylatrazine   Riedel-de-Haen, Germany 
IUPAC name: 6-chloro-N-ethyl-1,3,5-triazine-2,4-diamine 
• N-deisopropyldeethylatrazine  Labor Dr. Ehrenstorfer, Germany 
IUPAC name: 6-chloro-1,3,5-triazine-2,4-diamine 
• Hydroxy- Simazine    Sigma 
IUPAC name: 2-hydroxy-1,3,5-triazine-2,4-diamine 
• Methoxychlor    Labor Dr. Ehrenstorfer, Germany 
IUPAC name: 1,1,1-Trichloro-2,2-bis(4-methoxyphenyl)ethane 
• Mono-OH-Methoxychlor   Synthesized in our institute 
IUPAC name: 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl) ethane 
• Bis-OH-Methoxychlor   Synthesized in our institute 
IUPAC name: 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane 
• Tris-OH-Methoxychlor   Synthesized in our institute 
IUPAC name: 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(3, 4-dihydroxyphenyl)ethane 
• 4-n-nonylphenol    Alfa Aesar, Germany 
IUPAC name: 4-nonylphenol 
• p33-nonylphenol    See synthesis 
IUPAC name: 4-(3?-methyl-3?-octyl) phenol 
• p353-nonylphenol    See synthesis 
IUPAC name: 4-(3’, 5’-methyl-3’-heptyl) phenol 
• p363-nonylphenol    See synthesis 
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IUPAC name: 4-(3’, 6’-methyl-3’-heptyl) phenol 
3.7.2 Radiochemical 
• [Ring-U-
14
C]-Simazine   Novartis, Germany 
Specific activity: 1.18 MBq/mg 
Radioactive purity: > 98% (radioactive TLC) 
• [Ring-U-
14
C]-Methoxychlor   American Radiolabelled Chemicals, USA 
Specific radioactivity: 1.03 MBq/mg 
Radioactive purity: > 99% (radioactive TLC) 
• [Ring-U-
14
C]- 4-(3’, 5’-methyl-3’-heptyl) phenol Synthesis 
Specific radioactivity: 1.69 MBq/?g 
Radiochemical purity: 95% (HPLC/LSC-Radiodetection) 
• [Ring-U-
14
C]- 4-(3’methyl-3’-octyl) phenol Synthesis 
Specific radioactivity: 4.32 MBq/?g 
Radiochemical purity: 97% (radioactive TLC) 
3.8 Synthetic methods 
3.8.1 Synthesis of 33-nonanol 
Magnesium (2.01 g, 82.3 mmol) and a few crystals of I2 were put in a dry two-necked flask equipped 
with a reflux condenser, a drying tube (calcium chloride) and a dropping funnel. The mixture was 
heated in order to activate Mg. Then, anhydrous diethyl ether (10 ml) was added. 1-Bromopentane 
(82.3 mmol) (Fluka) dissolved in anhydrous diethyl ether (30 ml) was added slowly, so that the 
solution continued to reflux. When the reaction was completed, the mixture was heated to 40°C for 1 h 
until all Mg had completely disappeared. After cooling down to 0°C, a solution of 2-butanone (74.0 
mmol) (Fluka) in anhydrous diethyl ether (20 ml) was added slowly and then, the reaction mixture was 
heated to 40°C for 30 min. Subsequently, the resulting nonanol was protonated at 0°C with a mixture 
of crushed ice in water (20 ml) and additionally with aqueous NH4Cl (30 ml, 10%). The organic layer 
was separated, and the aqueous phase was extracted twice with diethyl ether (50 ml). The combined 
organic phases were washed three times with aqueous NaHSO4 (50 ml, 38–40%) and three times with 
saturated aqueous NaHCO3 (150 ml). Subsequently, the diethyl ether phase was dried over Na2SO4, 
and the solvent was removed under reduced pressure. The alcohol was obtained as colorless liquid.  
3.8.2 Synthesis of p33-NP, p353-NP, p363-NP 
12
C/
13
C 
To synthesize the nonylphenol isomers (p33-NP, p353-NP, p363-NP) the following compounds were 
mixed in different ratio as described in Table 3. (Ralph Vinken et al. 2002; Russ et al. 2005): 
• nonylalcohol: 3-methyl-3-octanol, 3,5-dimethyl-3-heptanol (Avocado), 3,6-dimethyl-3-heptanol 
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(Avocado) 
• phenol (Sigma) 
• BF3 as ether complex (Sigma) 
Table 3.5: Ratio of nonylalchool, phenol and BF3 for the synthesis of three branched nonylphenol isomers. 
 
 p363-NP p353-NP p33-NP 
Phenol 1 1 1 
Alchool 1 1.8 1.8 
BF3 4.4 11 4.4 
 
Phenol, nonylalcohol in correct ratio for the synthesis of the corresponding nonylphenol isomer and 
31.9 ml of petroleum ether were placed in a dry two-necked flask equipped with a reflux condenser 
and a drying tube (calcium chloride). 
The mixture was heated to 50°C and afterwards, BF3 (ether complex) in the appropriate ratio was 
carefully added. The reaction was allowed to run for 30 min.  
In a dry two-necked flask, a solution of the appropriate nonanol and phenol (300 mg, 3.19 mmol) in 
anhydrous petroleum ether (31.9 ml, boiling range from 60-90 °C) was heated under nitrogen at 50 °C. 
BF3 ether complex was added slowly in the appropriate quantity, and the resulting mixture was stirred 
for 30 min at 50 °C. Then, crushed ice and water (300 ml) were added and stirring was continued for 
30 min. The organic layer was separated, washed five times with water (300 ml) to remove excess 
phenol, and dried over Na2SO4. After removal of the solvent under reduced pressure, crude products 
were obtained and purified by column chromatography. 
The same procedures was used for the synthesis of 
13
C-p353-NP, starting from a 
13
C-labelled phenol 
(Sigma) 
3.8.3 Purification of nonylphenol isomers 
After synthesis, the p-NP isomers were purified on a silica gel column (Silica gel 60, Fluka, Germany) 
with hexane:ethylacetate (1:13 v/v) as eluting solvent. The purity (>98%) of the isomers was 
examined via GC/MS on a HP 5890 Serie II gas chromatograph (Agilent Technologies, Waldbronn, 
Germany) equipped with a FS-SE-54-NB-0.5 column (25m0.25 mm, 0.46 mm film thickness; CS 
Chromatographie Service), coupled to an HP 5971A mass selective detector (Agilent Technologies). 
The mass selective detector was used in electron impact mode (EI, electron energy: 70eV) and in the 
scan mode (mass range m/z 50-600). The temperature program was set to 50°C for 5 min, then 
increased with 10°C/min to 280°C, finally kept at 280°C for 5 min. The injector temperature was set to 
250°C and the interface temperature to 280°C. The injection volume was 1 µl in splitless injection. 
The carrier gas was helium (1 ml/min). Stock solutions were prepared in ethanol and stored at -20 °C. 
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3.8.4 Chlorinated derivatives of nonylphenol isomers 
The introduction of one and two chlorine atoms to the phenolic ring was accomplished by methods 
described before (Galve et al. 2002) with some modifications. 
 
 
Figure 3.3: Set up for nonylphenol chlorination. 
The flask containing nonylphenol was sealed with a septum. A balloon containing nitrogen was connected to the 
flask using a syringe, to ensure the absence of oxygen in the environment. The reagents were added using a 
syringe. 
Each NP isomer (100 mg, 0.45 mmol) was dissolved in anhydrous CH2Cl2 (1 ml). To this solution, 
SO2Cl2 (Fluka, Germany) (100 µl, 1.24 mmol) was added, followed by dropwise addition of 
anhydrous ethyl ether (175 µl, 1.67 mmol, 3 equiv). To obtain 2-chlor-4-nonyl-phenol (p4n-MClNP), 
2,6-dichlor-4-nonyl-phenol (p4n-DClNP), 2,6-dichlor-4-(3’-methyl-3’-octyl)-phenol (p33-DClNP), 
2,6-dichlor-4-(3’,5’-dimethyl-3’heptyl)-phenol (p353-DClNP) and 2,6-dichlor-4-(3’,6’-dimethyl-3’-
heptyl)-phenol (p363-DClNP), the reaction was kept at room temperature under nitrogen atmosphere 
(see Fig. 3.3), until the corresponding NP isomer was completely exhausted and the reaction mixture 
acquired an intense yellow colour. In contrast, synthesis of 2-chlor-4-(3’-methyl-3’-octyl)-phenol 
(p33-MClNP), 2-chlor-4-(3’,5’-dimethyl-3’heptyl)-phenol (p353-MClNP) and 2-chlor-4-(3’,6’-
dimethyl-3’-heptyl)-phenol (p363-MClNP) was performed in ice using half of the stoichiometric 
quantity of SO2Cl2. The mixture was brought to basic pH with 5% NaHCO3 and extracted with ethyl 
ether. The organic layer was washed with saturated NaCl solution, dried with MgSO4, filtered, and 
evaporated under reduced pressure to obtain a yellow oil. This was purified by column 
chromatography by using mixtures of hexane and ethyl acetate with increasing polarity. The purified 
mixture contained p-MClNP and p-DClNP. The two compounds were separated on preparative thin 
layer chromatography (TLC) (SIL G-200; Macherey-Nagel, Dueren, Germany) using tetrahydrofuran: 
hexane 2:98 (v/v). The purity of the compounds was examined via GC/MS, using the program 
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previously described for analysis of the NP isomers. Presence of the chlorine at the phenolic ring was 
demonstrated with 
1
H-NMR (500 Mhz, CDCl3 as solvent) measured on Varian Unity 500 instrument 
(Varian Inc., USA) recorded in ppm relative to tetramethylsilane (TMS). The chlorinated chemicals 
were dissolved in ethanol and kept at -20 °C. 
3.9 Metabolism studies 
The metabolism studies were performed differently with two different yeast systems: Yeast system 1, 
over-expressing yeast reductase (YR) and the respective cytochrome P450 monooxygenase, and yeast 
system 2, with YR regulated at genomic level and over-expresseding P450 monooxyigenase. The main 
differences will be described below. All experiments were conducted in duplicate. 
3.9.1 System 1 (over-expressing YR and Cytochrome P450) 
3.9.1.1 Preparation of cell culture pT2b6 and pU2c19 
The NC (non-transformed culture), YH499, was grown in YPAD plates, while cultures pT2b6 and 
pU2c19 were grown on minimal media plates lacking respectively tryptophane and uracil (SD-TRP, 
SD-URA). One colony was used to inoculate 20 ml of the corresponding media as pre-culture, o.n. at 
28°C. 1ml of the pre-culture was used to seeds 50 ml of media o.n. at 28°C. After the o.n. incubation, 
cells were harvested by centrifugation and resuspended in the same media containing galactose 
(YAPG/SG-TRP, SG-URA). Afterwards the radioactive compound was added to the media and the 
culture was incubated for 18 h or 72 h. A scheme of the preparation for metabolism study is reported 
in Fig. 3.4. 
 
 
Figure 3.4: Procedures for cells culture preparation for metabolism studies. 
The yeast cells were plated on selective media and incubated o.n at 28°C. One colony was used to inoculate the 
pre-culture. One ml of the pre-culture was used to inoculate the culture that was kept o.n. at 28°C. Than 
galactose was added and the culture was spiked with the radio-chemical. The incubation of the cells culture was 
of 18 h or 72 h. For the different yeast culture (pT2b6/pT2c19 or PY2b6/PY2c19) the corresponding media were 
used.  
3.9.2 System 2 (over-expressing only cytochrome P450) 
3.9.2.1 Preparation of cell culture PY2b6 and PY2c19 
The non-transformed yeast cells W(YR), called here negative control (NC), were grown on YPAD 
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media in the pre-culture (20 ml) and in YPED in the culture (50 ml); the recombinant culture PY2b6 
an PY2c19 were grown on SW(6) (20 ml) media in the pre-culture and in YPED media for the culture 
(50 ml). In YPED, glucose was present at low concentration (0.5%) so after an o.n. incubation at 
28°C, 5 ml of galactose, 20% (20 g/100 ml), and the radioactive compounds were added to the culture. 
A schematic preparation of the cells cultures for the metabolism study is reported in Fig. 3.4. 
3.9.3 Procedures for the metabolism studies 
After incubation of 18 or 72 hours with galactose and the radioactive or non-radioactive chemicals, the 
cells cultures were worked up. The work up scheme is displayed in Fig. 3.5.  
The media and cells were separated by filtration (> 0.6 µm, Whatman) under vacuum. The filter 
papers (Filter I), with the adhering cells, were air-dried and subject to combustion analyses (Biological 
Oxidizer OX 500, Zinsser, Harvey Instruments). The cells were re-suspended in Blighr-Dyer I 
(MetOH:CHCl3 2:1) and kept o.n. at "20°C, after which the yeast material was homogenized by 
sonication (Bandelin Sonoplus HD 200). Extract and cell debris were separated, and filter papers 
(Filter II) with the adhering cell debris were air-dried and subjected to combustion analysis. The media 
were extracted three times with EtOAc (100, 50, 50 ml). Parallels of media and cell extract were 
concentrated in vacuum, and residues were taken up in ethanol. The samples were then analyzed by 
thin-layer chromatography (TLC) and HPLC. 
 
 
Figure 3.5: Scheme of work up of metabolism studies of yeast cells cultures. 
The media and the cells were separated by filtration under vacuum. The paper filters (Filter I) were analyzed by 
combustion. The yeast cells were disrupted by sonication and the media and cell debris were separated by 
filtration. The filter papers (Filter II) were analyzed by combustion. The media was extracted with EtOAc for 3 
times. The media and cells extract were analyzed by TLC and HPLC. 
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3.9.4 Thin layer chromatography (TLC) 
Analytical TLC was performed on silica gel plates SILG-25UV254 (0.25mm) (Macherey-Nagel). The 
solvent systems were as follows, according to the different substances:  
• System I: Simazine; diethyl ether:ethyl acetate 1:1 (v/v);  
• System II: Methoxychlor; toluene: dichloromethane: ethyl acetate, 2:2:1 (v/v) + 1% acetic acid; 
• System III: nonylphenol isomers; diethyl ether:hexan , 1:1 (v/v); 
Separated radioactive zones were located and 
14
C was quantified by means of a Tracemaster 40 
radiochromatogram scanner (Berthold); non-labelled compounds were detected using UV light (254 
nm). 
3.9.5 High pressure liquid chromatography (HPLC) 
HPLC was performed with a Beckman System Gold Personal chromatograph equipped with a 
Nucleosil C18 column (250mm, 4mm; CS Chromatography Service) and a corresponding pre-column 
(20 mm, 4 mm). The system was completed with a Beckman Module 168 diode array detector and a 
Beckman 171 radioisotope detector equipped with a 2420 quartz cell (cell volume 370 µl; Raytest, 
Straubenhardt). Metabolites and parent compounds were separated by applying a gradient programme 
under the following conditions according to the different substances to be analyzed. 
 
Simazine (flow 0.8 ml/min) 
Solvent A %: KH2PO4 2 mM 80 65 15 15 80 80 
Solvent B %: MetOH 20 35 85 85 20 20 
Time (min.) 5 1 20 5 3 3 
 
Methoxychlor and Nonylphenol (flow: 1ml/min) 
Solvent A %: H2O+0.1% Acetic acid 65 0 0 65 65 
Solvent B %: Acetonitrle+0.1% Acetic acid 35 100 100 35 35 
Time (min.) 5 30 5 5 5 
The injection volume was 100 µl containing about 50000 dpm of 
14
C (samples from metabolism 
studies) or about 40000dpm (reference compounds). 
3.9.6 GC/MS for nonylphenol metabolites. 
GC-EIMS was performed on a HP 5890 Series II gas chromatography coupled to a HP 5971A mass 
selective detector (Hewlett-Packard). The system was equipped with a FS-SE- 54-NB-0.5 column (25 
m x 0.25 mm, 0.46 µm film thickness, CS Chromatography Service); carrier gas: He (1 ml/min); 
temperature program: 85°C for 5 min, 85 to 280°C at 10°C/min, 3 min at 280°C; injector: 250°C; 
interface: 280°C; splitless injection. Electron impact (EI) ms spectra were recorded using 70 eV 
electron energy. 
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3.10 Yeast estrogenic and androgenic screen (YES and YAS) 
3.10.1 Minimal media (MM) YES/YAS 
13.61g KH2PO4 (Sigma), 1.98 g (NH4)2SO4 (Merck), 4.2 g KOH (Merck) pellets, 0.2 g MgSO4 
(Sigma), 1 ml Fe2(SO4)3 (Aldrich) solution (40 mg/ 50 ml H2O), 50 mg L-leucine, 50 mg L-histidine, 
50 mg adenine, 20 mg L-arginine-HCl, 25 mg L-phenylalanine, 100 mg L-glutamic acid, 150 mg L-
valine and 375 mg L-serine were added to 1 l purified water. 
3.10.2 YES/YAS growing media and test media 
Mix the following sterile components: 
 
Growing media   
Compound Quantity  Concentrations 
Minimal media 45 ml - 
Glucose 5 ml 20% 
L-aspartic acid 1.25 ml 4 mg/ml 
Vitamin solution 0.5 ml - 
L-Threonine 0.4 ml 24 mg/ml 
CuSO4 0.125 ml 20 mM 
Yeast stock 0.25 ml - 
 
Vitamin solution 
Components Concentration 
Thiamine 8 mg 
Pyridoxine 8 mg 
Panthotenic acid 8 mg 
Inositol 40 mg 
Biotin solution 2mg/100ml 20 ml 
H2O to 200 ml 
 
The seeded media were incubated at 28°C o.n.  
For the assays 0.5 ml CPRG solution 10 mg/ml (sterile filtrated) was additionally added. The medium 
was seeded with 40 million cells/ml. The cells were counted at the microscope using a Neubauer cell 
counter. 
3.10.3 Estrogenic and androgenic assay for possible agonist.  
The estrogenic and androgenic potency of the p-NP isomers and their corresponding chlorinated 
derivatives was assessed using the yeast estrogenic screen and the yeast androgenic screen 
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(YES/YAS) according to the method previously described (Routledge and Sumpter 1996), with slight 
modifications (Rastall et al. 2004; Keiter et al. 2006). Yeast cells of Saccharomyces cerevisiae stably 
transfected with the gene coding for the human estrogen receptor [!-subtype] and a "-galactosidase 
reporter system lac-z were used for the assay (these were kindly provided by Prof. J Sumpter, Brunnel 
University, UK). The NP isomers and corresponding p-MClNP and p-DClNP were serially diluted in 
ethanol and tested in triplicates. Solutions of 17ß-Estradiol (Sigma) 1x10
-8
 M (E2) and of 
dihydrotestosterone (Sigma) 5x10
-8
 M were diluted in ethanol along a single row to provide a positive 
control; 100 !l of the ethanol vehicle were then added to wells containing neither samples nor E2. 
Solvent ethanol was allowed to evaporate. 200 !l assay medium containing growth components, 
4x10
7
/ml yeast cells, and 10 mg/ml of the chromogenic substrate chlorophenol red-"-D-
galactopyranosidase (CPRG, Roche Diagnostics) was added to each well. The plates were incubated at 
30°C for 48 h. The presence of human estrogen receptor agonists in the sample induces expression of 
the reporter gene and subsequent secretion of "-galactosidase into the medium. This causes hydrolysis 
of CPRG and thus, a colour change from yellow to red, which can be determined photometrically at 
540 nm as a measure for the estrogenic potency. Data were corrected for turbidity (yeast growth) using 
a second reading at 620 nm. Each test compound was tested in at least two indipendent assays. The 
EC50 values have been calculated from three replicates using the probit method. 
3.10.4 Estrogenic and androgenic assay of antagonist.  
A similar assay was used to test estrogen and androgen antagonist activity by measuring the ability of 
the different compounds to inhibit the color change induced by the natural ligand. In fact, the natural 
ligand was added to the corresponding assay at a concentration producing a sub-maximal response 
(65%). The chosen background for E2 and dihydrotestosterone (DHT) was 2.5x10
-10 
M and 1.25x10
-9 
M, respectively. Solutions of hydroxytamoxifen (Sigma) 2.5x10
-6 
M and of flutamide (Sigma) 4x10
-5
 
M were serially diluted in ethanol along the row to provide a positive control. 
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4 Results and discussion.  
4.1 Part A: Metabolism studies with recombinant yeast cell cultures. 
4.1.1 Genetically modified Saccharomyces cerevisiae with human cytochrome P450 
monooxygenase. 
The yeast Saccharomyces cerevisiae was transformed with two human genes (cDNA): cyp2b6 and 
cyp2c19 in two different ways: in one system the cytochrome P450 yeast reductase (CPYR) was over-
expressed by inserting the corresponding gene (cDNA) in the vector containing the cytochrome P450 
monooxygenase, in the other system the CPYR was controlled at a genomic level, inserting a 
galactose-inducible promoter upstream the CPYR ORF. The two systems were compared regarding 
expression and activity of the CYP2C19 and CYP2B6.  
4.1.1.1 System 1: Over-expressed of plasmid-encoded CPYR and cytochrome P450 
monooxygenase  
In this system, the CPYR and the cytochrome P450 monooxygenase were cloned in the same vector, 
which had two multi-cloning sites; in this way, both genes were over-expressed. 
4.1.1.1.1 Vector pESC-TRP and pESC-URA 
In Fig. 4.1, the structures of the two shuttle vectors pESC-TRP and pESC-URA are described. 
 
A B 
Figure 4.1: Description of vectors pESC-TRP (A) and pESC-URA (B). 
The two shuttle vectors demonstrated the following features: 1. pUC plasmid origin of replication and 
ampicillin-resistance gene, which allowed for replication and selection in E. coli; 2. yeast 2µ origin, which 
enabled autonomous replication of the plasmids in S. cerevisiae; 3. auxotrophic selectable marker genes: TRP1 
(A) and URA3 (B); 4. expression cassette, which contained the S. cerevisiae GAL1 and GAL10 promoters in 
opposing orientation, two multicloning sites (MCS) sequences, and a transcription termination sequence 
downstream of each promoter. 
The CPYR cDNA was inserted under the control of promoter GAL1 into both vectors, while cyp2b6 
cDNA was inserted under promoter GAL10 into vector pESC-TRP, and cyp2c19 cDNA was inserted 
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under the same promoter into vector pESC-URA.  
4.1.1.1.2 Amplification of CPYR from genomic DNA of S. cerevisiae 
The CPYR cDNA was amplified via PCR using Taq polymerase from genomic DNA of S. cerevisiae 
kindly provided from Dr. Martin Zimmermann, Department of Microbiology, RWTH Aachen 
University. The MCS1 (multi-cloning site 1) in the two vectors contained different cloning sites; 
therefore, two different pairs of primers (including different restriction enzymes sequences) were used 
for amplification of the CPYR gene (YRfor/rev primer for amplifying the gene to be inserted into 
vector pESC-TRP, and YRURfor/rev primers for amplifying the gene to be inserted into vector pESC-
URA). Fig. 4.2 shows the PCR products analyzed by gel electrophoresis. 
 
 
Figure 4.2: Amplification of CPYR cDNA by PCR for cloning into vector pESC-TRP and pESC-URA 
The CPYR cDNA was amplified with two different pairs of primers, one for each vector, containing different 
cloning sites. Lane 1: CPYR fragment for pESC-TRP vector, amplified with YRfor/rev primers having 
restriction enzyme sequences of ApaI and SalI; lane 2: CPYR fragment for pESC-URA vector, amplified with 
YR URA for/rev having restriction enzyme sequences of SalI and HindIII; lane 3: Lambda DNA/HindIII, 
Marker 2. 
4.1.1.1.3 Digestion of plasmids pESC-TRP and pESC-URA for CPYR insertion 
The two DNA fragement sequences obtained before were doubly digested with the appropriate 
restriction enzymes (ApaI/SalI for pESC-TRP and SalI/HindIII for pESC-URA vector), purified from 
agarose gel and the linearized vector was quantified by agarose gel electrophoresis. 
4.1.1.1.4 Insertion of CPYR gene in pESC-TRP and pESC-URA vectors 
The expression plasmids pTYR and pUYR were each constructed by insertion of CPYR cDNA 
linearized vectors by a ligation reaction. The vectors obtained were used for transforming the 
competent E. coli cells. Colonies growing after an o.n. culture were analyzed by colony PCR using the 
pair of primers GAL1for/rev. Forward and reverse primers were located on both sides of the MCS1 
outside the CYPR gene. Thus, amplification using a vector without insert CPYR contained would result 
in a PCR fragment of 288 bp, while amplification using a vector with intergrated CYPR would yield a 
fragment of approximately 2400 bp corresponding to the length of CPYR (2076 bp) and the distance 
between forward and reverse primers (288 bp). Fig. 4.3 reports the colony PCR of colonies 
transformed successfully and those without successful transformation. 
The plasmids were isolated and digested with an appropriate restriction enzyme to confirm the 
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presence of the insert. Finally the gene in both vectors was sequenced and the results obtained were 
compared with the sequence available in the database NCBI (National Center for Biotechnology 
Information; http://www.ncbi.nlm.nih.gov/). 
According to sequence analysis, the CPYR cDNA in pTYR showed one mutation causing a mutation 
in the expressed proteins (V
408
!I). The mutation was located in the FAD-binding domain of the 
protein and was traced back to a malfunction of the normal Taq polymerase use for the experiment 
instead of proof reading DNA polymerase. 
 
 
Figure 4.3: Colony PCR of four colonies of E. coli after transformation with pUYR vector 
Lane 1: GeneRuler 1kb DNA Ladder; Lane 2, 3 and 5: colonies transformed with the vector not ligated with the 
insert CPYR; the fragment size was 288 bp, distance in the vector between the primers, due to location of the 
sequences of the primers on both sides of MCS1 outside CYPR; Lane 4: colony positively transformed with 
vector ligated with CPYR; this was confirmed, because the PCR product had a size of approximately 2400 bp 
corresponding with the distance of the two primers (288 bp) and the length of the gene CPYR (2076 bp). 
4.1.1.1.5 Cloning cyp2b6 and cyp2c19 in pTYR and pUYR 
The cyp2c19 and cyp2b6 cDNAs were amplified via PCR from the corresponding vector pCW’ using 
the pairs of primers cyp2c19for/rev and cyp2b6for/rev, respectively; the primers included the cloning 
sites SpeI and BglII. 
The resulting cDNA were digested and purified as described for CPYR and cloned in the expression 
vectors pTYR (cyp2b6) and pUYR (cyp2c19), in order to obtain the vectors pTYRb6 and pUYRc19, 
respectively (Fig. 4.4). 
The vectors were used to transform competent cells of E. coli. Colonies appeaing after an o.n. culture 
were analyzed by colony PCR using the pair of primers GAL10for/rev. Forward and reverse primer 
were located on both sides of MCS2 outside the P450 cDNA. In case the vector would not contain 
the inserted CYP450, the fragment obtained via PCR was expected to be 222 bp, whereas a fragment 
of approximately 1698 bp for cyp2b6 and 1660 bp for cyp2c19 (corresponding to the length of cyp2b6, 
1476 bp, or cyp2c19, 1438 bp, and the distance between forward and reverse primers, 222 bp) was 
expected in case if successful cloning (Fig. 4.5). 
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Figure 4.4: Amplification of the cyp2b6 and cyp2c19 from the corresponding vcctor pCW’ for cloning in 
the vector pTYR and pUYR, respectively. 
Lane 1: Gene Ruler Ladder Plus; Lane 2: cyp2b6 PCR fragment, including cloning sites SpeI/BglII; lane 3: 
cyp2c19 PCR fragment, including cloning sites SpeI/BglII 
 
A B 
Figure 4.5: description of vectors pTYRb6 (A) and pUYRc19 (B). 
In both vectors, the CPYR and the corresponding cytochrome P450 monooxygenase cDNAs were under the 
control of a galactose-regulated promoter. This expression vectors were used to transform the yeast S. cerevisiae 
YPH499, which were subsequently used for metabolism studies with different xenobiotics. 
 
 
Figure 4.6:Colony PCR of cyp2b6 and cyp2c19 from vectors pTYRb6 and pUYRc19 
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Lane 1, 2, 3: colonies positively transformed with vector containing cyp2c19 cDNA; the fragment size was 1660 
bp, 1438 bp size of cyp2c19 plus 222 bp fragment size between primers in the vector. Lane 4: colonies 
transformed with the vector not ligated with cyp2b6 cDNA; the fragment size was 222 bp, the distance in the 
vector between primers. Lane 5, 6, 7: colonies positively transformed with the vector ligated with cyp2b6; the 
fragment size was 1698 bp, 1476 bp size of cyp2b6 plus 222 bp fragment size between primers in the vector. 
Lane 8: GeneRuler 1kb DNA Ladder Plus 
To confirm the cloning, the vectors were isolated form the bacteria and digested with appropriate 
enzymes. The cDNAs were sequenced; the results showed that no mutation had occurred during the 
cloning procedure. 
The vectors were used to transform the yeast S. cerevisiae YPH499 in order to obtain the two yeast 
cultures: pT2b6 and pU2c19 subsequently used for metabolism studies. 
After transformation into the yeast cells, the insertion of the correct plasmids was verified by colony 
PCR using the internal primers of cyp2b6 and cyp2c19: 2b6forint/2b6revint and 
2c19forint/2c19revint, as described in Fig. 4.7. 
 
 
Figure 4.7: Colony PCR of yeast cells transformed with pTYRb6 and pUYRc19 plasmids. 
Lane 1: GeneRuler 1kb DNA Ladder Plus. Lane 2, 3: colonies positively transformed with pTYRb6 vector; the 
fragment size was 533 bp, amplified with primers located inside cyp2b6 cDNA. Lane 4, 5: colonies positively 
transformed with the vector pUYRc19; the fragment size was 524 bp, amplified with primers located inside 
cyp2c19 cDNA. 
4.1.1.2 System 2: CPYR with expression controlled at a genomic level and plasmid-
encoded over-expressed cytochrome P450 monooxygenase. 
In this system, the CPYR was controlled at genomic level; the plasmid-encoded cDNA was put under 
control of a galactose-inducible promoter. The cytochrome P450 monooxygenases were cloned into an 
expression vector exhibiting one multicloning site. In this way, only the CYP 450s were over-
expressed in the resulting transgenic yeast cells. 
4.1.1.2.1 Description of the engineered yeast cells W(YR) 
The yeast W(YR) was obtained from Dr. Denis Pompon, France and had been engineered in order to 
control the expression of genomic cytochrome P450 yeast reductase (YR). The CPYR gene had been 
put under control of galactose-inducible promoter GAL10-CYC1 by means of an integrative vector. In 
the yeast strain, the recombination event occurred outside the ORF of the CPYR gene, and led to a 
promoter substitution without modification in the CPYR ORF. W(YR) cells do not express detectable 
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levels of YR when grown on glucose, but high expression levels are achieved with galactose (Pompon 
et al. 1996). 
4.1.1.2.2 Description of the vector pYeDP60 
The vector was obtained from Dr. Denis Pompon, France. This shuttle vector shows two auxotrophic 
selectable markers, ADE2 and URA3. Because integration of the GAL10-CYC1 galactose-inducible 
promoter was selected based on URA3, this marker cannot be used to select further transformation 
events, except if it is recovered by selecting spontaneous or induced ura3 mutants (marker 
inactivation) as 5-fluoroorotate-resistant clones. The selection marker used to select the recombinant 
yeast was the ADE2. For the description of the vector, see Fig. 4.8. 
 
Figure 4.8: Description of the vector pYeDP60. 
The shuttle vector showed the following features: 1. pUC plasmid origin of replication and ampicillin-resistance 
gene which allowed for replication and selection in E. coli; 2. yeast 2µ origin, which enabled autonomous 
replication of the plasmids in S. cerevisiae; 3. auxotrophic selectable marker gene: ADE2; 4. expression cassette, 
which contained the GAL10-CYC1 galactose-inducible promoter, multicloning site (MCS) sequences, and 
transcription termination sequence downstream of the promoter. 
4.1.1.2.3 Genes cyp2b6 and cyp2c19 
The two genes cyp2b6 and cyp2c19 were amplified from the corresponding vectors pCW’ by PCR 
(Fig. 4.9) using the pairs of primers 2b6pYeDPfor/rev and 2c19pYeDPfor/rev. The primers contained 
the necessary restriction sites for cloning of the genes into the vector pYeDP60 BamHI and KpnI, and 
KpnI and SacI, respectively. The PCR product was purified and doubly digested with the restriction 
enzymes required for cloning the gene into the vector pYeDP60. 
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Figure 4.9: Amplification of genes cyp2b6 and cyp2c19 from the corresponding pCW’ vector by PCR for 
cloning into vector pYePD60.  
Lane 1: Gene Ruler Ladder Plus; Lane 2: cyp2b6 PCR fragment, including cloning sites BamhI/KpnI; Lane 3: 
cyp2c19 PCR fragment, including cloning sites KpnI/SacI 
4.1.1.2.4 Insertion of cyp2b6 and cyp2c19 into plasmid pYeDP60 
After double digestion with appropriate restriction enzymes, the vector was purified and quantified by 
agarose gel electrophoresis. Genes cyp2b6 and cyp2c19 cDNA were ligated with the vector in order to 
obtain vectors, pYe2b6 and pYe2c19, respectively. 
The new construct, vector pY2b6, is shown in Fig. 4.10 . Both vectors obtained were used to transform 
the competent E. coli cells; success of ligation was demonstrated by colony PCR. The plasmids of the 
positive colonies were isolated and digested as further confirm of the expected ligation. Finally, the 
cDNA was sequenced, and no mutation event was found. 
 
 
Figure 4.10: Construction of vector pYe2b6. 
The vector was constructed by inserting the cyp2b6 cDNA into the vector pYeDP60 using the cloning sites 
BamHI/KpnI. The gene were put under the control of the galactose-inducible fused promoter GAL10-CYC1. 
The two vectors obtained (pYe2b6 and pY2c19) were used to transform the competent yeast cells of S. 
cerevisiae, strain W(YR). Incorporation of the plasmids was proved by colony PCR, as described in 
Fig. 4.11. The resulting yeast cell cultures, designated as pY2b6 and pY2c19, were used for 
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metabolism studies using different xenobiotics, including the nonylphenol isomers. 
 
 
Figure 4.11: Colony PCR of the yeast cells transformed with pYe2b6 and pYe2c19 plasmids. 
Lane 1: GeneRuler 1kb DNA Ladder Plus. Lane 2, 3, 4: colonies positively transformed with the pYe2b6 vector; 
the fragment size was 533 bp, amplified with primers inside the cyp2b6 cDNA. Lane 5, 6, 7: colonies positively 
transformed with the vector pYe2c19; the fragment size was 524 bp, amplified with primers inside the cyp2c19 
cDNA. 
4.2 Metabolism studies with the recombinant yeast cell cultures. 
The two systems of recombinant yeast cells were used to perform metabolism studies in vivo using 
different xenobiotics (simazine and methoxychlor) and in particular branched NP isomer (p353-NP), 
in order to assess the functional activity of the system and to try to identify metabolites generated in 
these studies. All metabolism studies were performed in duplicate, and calculations of radioactive 
balance were always referred to amounts of the radioactive substance applied. Portions of metabolized 
(radioactive) substance were calculated on basis of the radio-TLC, except when differently specified. 
4.2.1 Metabolism studies using the yeast system 2 
The recombinant yeast cells cultures PY2b6 and PY2c19 were used to perform metabolism studies 
using simazine, methoxychlor and one nonylphenol isomer. 
4.2.1.1 Verification of expression and catalytic activity of CYP2C19 in the yeast cells 
culture PY2c19 
4.2.1.1.1 Metabolism study with pY2c19 cell cultures of simazine with 18 h of incubation  
In vitro metabolism experiments executed using recombinant yeast microsomes which expressed 
CYP2C19 showed that the percentage of metabolized simazine was 50% (Inui et al. 2001). Therefore 
to verify expression and catalytically active protein CYP2C19 in yeast cell culture PY2c19, 
14
C-
simazine was used as substrate. In Fig. 4.12, the chemical structure of simazine and its metabolites 
hydroxy-simazine, dethyl-simazine and didethyl-simazie are displayed.  
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Figure 4.12: Structure of simazine and its metabolites deethyl-simazine, dideethylsimazine and hydroxy-
simazine. 
 
This study was performed incubating the NC and the PY2c19 cell culture for 18 h with 11.6 !g of 
14
C-
simazine per assay. The Fig. 4.13 shows the distribution of the recovered radioactivity between cells 
and media extract in both cultures. 
 
 
Figure 4.13: Balance of radioactivity observed after 18h incubation in the the metabolism study using NC 
and PY2c19 cell cultures spiked with 
14
C-simazine. 
The distributions of radioactivity between the compartments are reported: in both, the negative control (NC) and 
the recombinant culture (PY2c19) the radioactivity was mainly present in the media extract (ME), while in the 
cells extract (CE), only a small portion of radioactivity was present. 
The recovered radioactivity was mainly present in the extracts of the media of both, the NC and the 
PY2c19 cell cultures. In the cells extract, below 1% of the applied radioactivity was present. The non 
extractable radioactivity (NER) – determined before and after cell disruption –amounted to less than 
0.2%; for this reason, these data were not included in the graph. The high recovery of the radioactivity 
was most probably favoured by the comparatively high polarity of simazine. 
The media extract was analyzed by radio-TLC, and the results are shown in Fig. 4.14. 
The corresponding results demonstrated that the recombinant cell culture was not capable to 
metabolize simazine to a higher extent than the NC. The identity of simazine (detected with radio-
TLC) was proven by comparison (co-chromatography) with the Rf of an authentic non-labelled 
reference. Additionally, the samples were analyzed by means of HPLC; the corresponding 
chromatograms only showed the presence of non-metabolized simazine in the samples. Probably due 
to detection limits, the minor 
14
C components detected by TLC were not found by HPLC. In table 4.1, 
the Rf values for TLC and R.T. values (retention time) for HPLC of simazine and its available 
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metabolites (non-labelled references and 
14
C-simazine) are displayed.  
 
 
Figure 4.14: TLC radio-chromatogram of the extracts of the media of the NC and the PY2c19 culture 
incubated with 
14
C-simazine for 18 h. 
Both, the negative control and the recombinant cell culture transformed simazine similarly and only to a low 
extent. The identity of the simazine was proven by co-chromatography with an authentic reference. (1) 
14
C 
remaining at the start of the plate; (2) co-chromatographing with an authentic reference of deethyl-simazine; (3) 
co-chromatographing with an authentic reference of simazine. 
Table 4.1: Rf  for TLC and R.T. for HPLC of simazine and its metabolites hydroxy-simazine, deethyl-
simazine and dideethyl-simazine 
 
 Rf for TLC R.T. (min) for HPLC 
Simazine 0.49 20.08 
14
C-Simazine 0.49 20.58  
Hydroxy-simazine 0.13 13.55 
Deethyl-simazine 0.39 12.75 
Dideethyl-simazine 0.24 5.22 
 
The difference between the R.T. of non-labelled and 
14
C-labelled simazine (approximately 0.5 min) 
resulted from the length of the capillary between the UV detector and and the radio-detector, which 
was installed downstream. The fact that the recombinant cell culture was not capable to metabolize 
simazine to a higher extent than the non-transformed yeast culture could have been due to the 
following reasons: 
• protein CYP2C19 was not expressed, or was expressed but not functional; 
• induction by galactose for 18 h was not sufficient for high expression levels of CYP2C19. 
In order to verify whether a longer induction period using galactose would result in a higher CYP2C19 
protein level and higher metabolization of simazine, the following studies using the yeast cell cultures 
were performed with an incubation and induction period (
14
C-simazine and galactose, respectively of 
72 h. 
4.2.1.1.2 Metabolism study using the pY2c19 cells and simazine with 72 h of incubation. 
This study was performed incubating the NC and the PY2c19 cell culture for 72 h with 13.2 !g of 
14
C-
  4. Results and discussion 
- 53 - 
simazine per assays with simultaneous presence of inductor galactose. Fig. 4.15 shows the 
distributions of recovered radioactivity between cells and media extract for both cultures. According to 
these results, the distributions of 
14
C were quite similar as those obtained in the previous experiment. 
 
Figure 4.15: Balance of radioactivity observed after 72h incubation in the metabolism studies using NC 
and PY2c19 cell cultures spiked with 
14
C-simazine. 
The distributions of radioactivity between the compartments are reported: in both, the negative control (NC) and 
the recombinant culture (PY2c19), the radioactivity was mainly present in the extracts of the media , while in the 
cell extracts (CE), only a small portion of radioactivity was present. 
The extract of the media – representing the major portion of recovered 
14
C, was examined by radio-
TLC, and the results are reported in Fig. 4.16. TLC analysis showed the presence of higher portions of 
metabolites in the cells culture expressing CYP2C19 as compared to the NC. This result was regarded 
as confirmation of the expression of catalytically active enzyme CYP2C19 within 72 h of incubation 
with 
14
C-simazine and simultaneous induction by galactose. 
 
 
Figure 4.16: TLC radio-chromatogram of the extracts of the media of the NC and PY2c19 cultures after 
incubation with 
14
C-simazine for 72 h and with simultaneous induction by galactose. 
The PY2c19 cell culture metabolized simazine to a larger extent as compared to the NC. (1) 
14
C remaining at the 
start of the plate; portion represented by this peak was small with NC as compared to PY2c19 culture, (2) 
deethyl-simazine, as proven by co-chromatography with an authentic reference; (3) simazine, as proven by co-
chromatography with a standard of simazine. 
As described in Fig. 4.17 simazine was metabolized only to a minor extent by the NC culture; in fact 
the portion of the applied radioactivity corresponding to not-metabolized simazine was 78%. Whereas 
in culture PY2c19 the portion of the applied radioactivity corresponding to not-metabolized simazine 
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was almost 41%. The difference between these two values (simazine portion in the NC and PY2c19 
cultures) represented the quantity of simazine that was effectively metabolized (circa 40%) to more 
polar metabolites according to evaluation of the results obtained by radio-TLC results (Fig. 4.16). 
 
 
Figure 4.17: Portion of radioactivity represented by the peaks detected during radio-TLC of the extracts 
of the media derived from NC and PY2c19 cells cultures. 
In the NC, 78% of the radioactivity contained in the samples was due to 
14
C-simazine. The portion of 
radioactivity in the PY2c19 cells cultures corresponding with simazine was about 41%. The difference between 
these 2 values represented the portion of simazine converted to metabolites.  
The extracts of the media were additionally analyzed by HPLC using as non-labelled standards as 
references, as shown in Fig. 4.18. The main metabolite found in the media of the PY2c19 cultures 
exhibited an RT similar to that of reference hydroxy-simazine, while the second metabolite, also 
present in the NC at lower concentration, had an RT comparable to that of deethyl-simazine.  
These results thus, demonstrated that the main metabolite produced by the yeast cells culture 
expressing CYP2C19 was a hydroxylated derivative of simazine. As described in literature, 
chlorotriazines in general are metabolized by both, the 2-hydroxylation and N-dealkylation pathways 
in resistant corn (Shimabukuro 1968); partial N-dealkylation accompanied by slow hydrolysis was 
observed using a soluble fraction from goose, pig or sheep liver-homogenates (Shahamat U. Khan 
1979). In human liver microsomes, the major metabolites derived from triazines are mono-dealkylated 
forms, i.e. desethyl and desisopropyl derivatives depending on the chemical structures of the parent 
compounds; metabolites of atrazine and propazine with hydroxylated isopropyl groups were detected, 
but to a lesser extent. Other metabolites formed in vivo and found in human urine are fully dealkylated 
metabolites (in case of atrazine: desethyldesisopropyl-atrazine) and several 2-hydroxylated 
metabolites (Sanderson et al. 2001). Regarding simazine, no data are available in the literature on in 
vivo metabolism studies and metabolites identification performed with a recombinant yeast system. 
Due to its polarity and Rf value, which was comparable (Fig. 4.18) to that of hydroxy-simazine, the 
metabolite detected as peak 6 was identified with a hydroxylated metabolite of simazine – a 
hypothesis, which is regarded as most reasonable. However, hydroxylation of triazines may not 
exclusively occur at postion 2 substituting a hydroxy group in place of chlorine (2-hydroxylation); 
alkyl-hydroxylation was previously reported for triazines other than simazine (Adams et al. 1990; 
Lang et al. 1996). The present results however clearly point to hydroxylation at position 2, since alkyl-
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hydroxylated derivatives of simazine should exhibit a distinctly lower polarity than 2-hydroxylated 
compounds (alkyl-OH vs. aromatic/phenolic OH). To confirm the structure of this and the other 
metabolites, further investigation are required using e.g. GC/MS and NMR. 
 
 
Figure 4.18: HPLC results of the extracts of the media of the NC and PY2c19 cultures incubated with 
14
C-
simazine for 72 h of incubation. 
Peak 1: Deideethyl-simazine non-labelled standard; Peak 2: deethyl-simazine non-labelled standard; Peak 3: 
hydroxy-simazine non-labelled standard; Peak 4: simazine non-labelled standard; Peak 5: 14C-simazine found in 
the NC and PY2c19 extracts; Peak 6: metabolite of 
14
C-simazine found only in the PY2c19 extracts and 
identified as hydroxy-simazine according to co-chromatography with the authentic reference; Peak 7: metabolite 
of 
14
C-simazine, found in higher concentration in the PY2c19 derived extracts than in the NC derived extracts, 
identified as deethyl-simazine according to co-chromatography with the authentic reference. 
On the whole, this results clearly showed that CYP2C19 was expressed and functional in the yeast 
cells; this finding was in accordance with literature data (Inui et al. 2001), where is reported that 50% 
of simazine was metabolites using a microsomes system. 
4.2.1.1.3 Verification of expression and catalytic activity of CYP2B6 in yeast cells culture 
pYe2b6 
In vitro metabolism conducted in microsomes derived from recombinant yeast expressing CYP2B6 
showed that the portion of metabolized simazine was only 25% (Inui et al. 2001). Therefore, to verify 
expression and catalytic activity of the protein CYP2B6 in the present transgenic yeast cell culture 
PY2b6, 
14
C-simazine was regarded less suitable; instead 
14
C-methoxychlor was used as test substrate. 
In Fig. 4.19, the structure of methoxychlor and its metabolites monohydroxy-, bishydroxy-, 
trishydroxy- and catechol-methoxychlor are shown. In our laboratory, an authentic non-labelled 
standard of cathechol-methoxychlor was not available. As standard for this biotransformation product, 
a corresponding sample resulting from a metabolism study previously performed on methoxychlor in 
our laboratory was used; the structure of catechol-methoxychlor contained in this sample was 
confirmed by GC/MS (Joussen 2008). 
This study was performed by incubation of the NC and PY2b6 cell cultures for 72 h with 26 !g of 
14
C-
methoxychlor (induction by galactose as described before). Fig. 4.20 shows the distributions of 
recovered radioactivity among cells and extracts of the media as well as the non-extractable 
radioactivity, NER1/2 (cf. Materials and Methods) concerning both cultures. The distributions of 
14
C 
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were considerably different between the NC and PY2b6 cells. In fact in the NC, most of the 
radioactivity was present in the NER 2 (not extractable 
14
C present on paper filters after cell 
disruption) followed by those portions present in the cell extracts. In the PY2b6 cell cultures, the 
majority of 
14
C was present in the extracts of the media, followed by cell extracts. 
 
   
   
Figure 4.19: Structure of the insecticide methoxychlor and its metabolites monohydroxy-, bishydroxy-, 
trishydroxy- and catechol-methoxychlor. 
 
 
Figure 4.20: Balance of radioactivity observed after 72 h incubation in the metabolism studies using the 
NC and PY2b6 cell culture spiked with 
14
C-methoxychlor. 
Distribution of 
14
C is shown between the different compartments. NC culture: higher portions of radioactivity 
were present in the NER2 (non-extractable 
14
C on filters after cells disruption), followed by cell extracts; in 
media and NER1 (non-extractable 
14
C on filters before cell disruption) portions of radioactivity were 
approximately 5%. PY2b6 culture: the radioactivity is mainly present in extracts of media (ME), followed by the 
cell extracts (CE); in NER1 and 2, only a small portions of radioactivity were detected. 
The difference of the portions of radioactivity present in the media was observed between the NC and 
PY2b6 cells cultures; this difference amounted to 46% in favour of the PY2b6 cells and was 
tentatively attributed to higher portions of hydrophilic metabolites produced by these cells. Total 
recovered radioactivity was approximately 90% with both cells cultures. Probably, this was due to the 
low aqueous solubility of methoxychlor and concomitant volatility from aqueous solution during 72h 
of incubation. 
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Media and cell extracts were analyzed by radio-TLC and the results are displayed in Fig. 4.21. The 
analysis clearly showed the presence of higher portions of metabolites in the cells culture expressing 
CYP2B6. This finding was thought to result from expression and catalytic activity of the P450 enzyme 
during 72h of incubation with the 
14
C-labelled substrate and inductor galactose. 
 
A B  
Figure 4.21: TLC radio-chromatogram of the extracts of the media (A) and cell extracts (B) derived from 
NC and PY2b6 cell cultures incubated with 
14
C-methoxychlor for 72 h.  
The PY2b6 cell culture metabolized methoxychlor to a higher extent as compared to the NC cultures. (A) extract 
of media: in the NC cells, the radioactivity was mainly due to parent methoxychlor (Peak 5; identified by co-
chromatography with an authentic reference), whereas in the PY2b6 culture, methoxychlor was almost 
completely transformed in favour of more polar metabolites. (B) cell extracts: in NC cell cultures, the major 
portion of 
14
C was due to non-metabolized methoxychlor (Peak 5), whereas in the PY2b6 cell cultures, only a 
small portion of applied methoxychlor remained non-metabolized. 
In the NC culture, methoxychlor was metabolized to a minor extent; thus, in media and in cell extracts 
the majority of radioactivity was co-chromatographed with an authentic reference of the insecticide 
(82% of 
14
C in extracts of media, 99% in cell extracts). In contrast, most of the radioactivity present in 
the extracts of the media derived from the PY2b6 culture, was due to methoxychlor metabolites (Peak 
1: 57% of 
14
C; Peak 2: 37% of 
14
C). In the cell extracts, the portion of non-metabolized methoxychlor 
amounted to approximately 5% (Peak 5), 60% of the radioactivity eluted as Peak 2 and 27% as Peak 1. 
In the Table 4.2, Rf (TLC) and R.T. (HPLC) values of methoxychlor and its metabolites are listed.  
Extracts of media and cells were analyzed by HPLC using as references the corresponding non-
labelled standards; results are shown in Fig. 4.18. The main metabolite produced by the PY2b6 
(media, cells) was co-chromatographing with catechol-methoxychlor available as reference in a 
sample from a previous metabolism study (Joussen 2008). This finding indicates that CYP2B6 was 
expressed and functionally active. According to the literature on microsomes from Cyp2b6-
recombinant yeast, CYP2B6 is capable to metabolize 25% of the applied methoxychlor (Inui et al. 
2001). These data can be compared to the present data in a qualitative but certainly only in a 
semiquantitative manner, because concentrations of biomass (yeast cells vs. microsomes) and 
methoxychlor and duration of incubation differed between the two systems. Nevertheless in the 
present whole cell-system, the portion of non-metabolized methoxychlor remaining after 72 h of 
incubation was 5% of applied radioactivity according to radio-TLC and 17% according to HPLC 
analysis. These results point to a metabolic rate for methoxychlor of 83-95%. The main factor 
accounting for the difference in turnover between in vivo- and in vitro-system was supposed to be the 
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incubation period; experiments with microsomes are prevailingly limited to a few hours due to the 
limited lifetime of the proteins present in this artificial biochemical system.  
Table 4.2: Rf (TLC) and R.T. (HPLC) of authentic references of methoxychlor and its metabolites 
monohydroxy-, bishydroxy-, trishydroxy- and catechol-methoxychlor. (n.a.= not available)  
 
Compound Rf for TLC R.T. (min.) for HPLC 
Methoxychlor 0.66-0.69 26.18007 
14
C-Methoxychlor 0.66-0.69 25.08-25.29 
Monohydroxy-methoxychlor 0.50-0.53 20.570 
Bishydroxy-methoxychlor 0.38 15.721 
Trishydroxy-methoxychlor 0.19-0.20 11.877 
Catechol-methoxychlor n.a. 17.810 
 
 
Figure 4.22: HPLC results of extracts of media derived from NC and PY2b6 culture incubated with 
14
C-
methoxychlor for 72 h. 
Peak 1: Trishydroxy-methoxychlor; Peak 2: Bishydroxy-methoxychlor; Peak 3: Monohydroxy-methoxychlor; 
Peak 4: Methoxychlor; Peak 5: Catechol-methoxychlor. In the extracts of media and cells derive from the NT 
cultures, no metabolites were detected, the radioactivity present was consisted of methoxychlor (as determined 
by co-chromatography with a non-labelled standard). In the exttract of the media derived from the PY2b6 
cultures, the main metabolite was identified with catechol-methoxychlor, followed by trishydroxy- and 
bishydroxy-methoxychlor. In cell extracts of the PY2b6cultures, low portion of non-metabolized methoxychlor 
was detected; the main metabolite was catechol-methoxychlor followed by bishydroxy-methoxychlor and a trace 
of monomethoxy-methoxychlor. 
These results showed that the main metabolite produced by the yeast cells culture expressing CYP2B6 
was catechol-methoxychlor. According to HPLC, the portion of 
14
C found in media and cell extracts 
was traced back to 45% of catehcol-methoxychlor, 20% of trishydroxy-methoxychlor, 5% of 
bishydroxy-methoxychlor, 3% of non-metabolized methoxychlor, and 0.6% of monohydroxy-
methoxychlor. These results thus, confirmed literature data which proposed catechol-methoxychlor as 
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main metabolite formed by CYP2B6 as determined by a microsome system (Hu and Kupfer 2002). 
CYP2B6 was thought to exhibit significant ortho-hydroxylation activity towards monohydroxy-
methoxychlor leading to metabolite catechol-methoxychlor. In contrast, it was also assumed that this 
P450 enzyme was not effective concerning demethylation of monohydroxy-methoxychlor yielding 
bishydroxy-methoxychlor and trishydroxy-methoxychlor (Hu and Kupfer 2002). In our in vivo-system, 
20% of the radioactivity spiked as 
14
C-methoxychlor was attributed to trishydroxy-methoxychlor; this 
finding differs from literature data. The difference could have been due to the incubation time used in 
the experiments. In the microsome in vitro-system, the incubation period used (1 h) might not have 
been sufficient for a further demethylation of catechol-methoxychlor. In the present studies, 
trishydroxy-methoxychlor appeared to be rather a product of demethylation of catechol-methoxychlor 
(one reaction step) than a product of hydroxylation of bishydroxy-methoxychlor (2 steps reaction). In 
order to confirm this hypothesis, further studies are required. 
4.2.1.1.1 Western blot of PY2c19 and PY2b6 cells cultures 
Western blot analysis was carried out in order to confirm the expression of human CYP2C19 and 
CYP1B6 from the corresponding integrated genes. The result of the Western blot analysis for the 
culture PY2b6 shown in Fig. 4.23 revealed the expression of human CYP2B6, whereas no bands could 
be detected in non-transformed cells. 
Consequently, the presence and expression of the human CYP genes could be demonstrated in all of 
the putative transgenic cultures, PY2b6 and PY2c19. 
 
 
Figure 4.23: Western blot of PY2b6 cell cultures in order to confirm the expression of CYP2B6. 
The proteins were separated using a SDS-PAGE. The immunochemical identification of CYP2B6 was carried 
out using specific antibody (anti-human CYP2B6) and unspecific antibody (anti-rabbit horseradish peroxidase) . 
Lane 1: Positive control, CYP2B6 microsomes; Lane 2: CYP2B6 expressed in the PY2b6 cells culture; Lane 3: 
Negative control,   
4.2.1.2 Metabolism study of nonylphenol isomers by PY2c19 and PY2b6 cells culture 
After verification the expression and activity of the enzymes CP2B6 and CYP2c19, the yeast cells 
cultures where used to perform metabolism studies of nonylphenol isomers. The metabolism studies 
were performed with 72 h of incubation of the radioactive substance in presence of galactose. 
4.2.1.2.1 Metabolism study of p353-NP by PY2c19 yeast cells culture 
In vitro metabolism conduced in the recombinant yeast microsomes expressing CYP2C19 showed that 
the percentage of metabolized 4-n-NP was 29% (Inui et al. 2001). In this study the metabolism study 
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was performed with the branched isomer p353-NP, and in Fig. 4.19 its structure is reported. 
 
 
Figure 4.24: Structure of p353-NP (please add here complete IUPAC name for this compound) 
 
This study was performed incubating the NC and the PY2c19 cell culture for 72 h with 29 !g of 
14
C-
p353-NP. Fig. 4.25 shows the distributions of recovered radioactivity among cells and extracts of the 
media as well as the non-extractable radioactivity, NER1/2 (cf. Materials and Methods) concerning 
both cultures. The distributions of 
14
C were not considerably different between the NC and PY2c19 
cells. In fact in both cells culture, most of the radioactivity was present in the cells extract (43% for 
NC and 46% for PY2c19 cell culture), followed by those portions present in the NER 2 (not 
extractable 
14
C present on paper filters after cell disruption). These amounted to 16% for the NC and 
21% for the PY2c19 cell cultures.  
 
Figure 4.25: Balance of radioactivity observed after 72 h incubation in the metabolism studies using the 
NC and PY2c19 cell culture spiked with 
14
C-p353-nonylphenol. 
Distribution of 
14
C is shown between the different compartments. In both cells cultures (NC and PY2c19) higher 
portions of radioactivity were present in the cell extracts followed by NER2 (non-extractable 
14
C on filters after 
cell disruption); in media and NER1 (non-extractable 
14
C on filters before cell disruption) portions of 
radioactivity were less than 10 % and 15%, respectively. 
The similar distribution of radioactivity in the different compartments could indicate that there was no 
production of a higher portions of hydrophilic metabolites produced by the recombinant cells cultures, 
as it had occurred in the case of methoxychlor in the PY2b6 cells culture. Total recovered radioactivity 
was approximately 90% with both cells cultures. Probably, this minor loss was due to the low aqueous 
solubility of nonylphenol and concomitant volatility from aqueous solution during 72h of incubation. 
The cell extracts were analyzed by radio-TLC and the results are displayed in Fig. 4.26. The analysis 
clearly showed that the cell culture expressing CYP2C19 was not able to metabolize the p353-NP 
isomer. In fact, the radioactivity in both cultures was mainly due to the parent compound p353-NP 
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isomer (~85%). This finding was not thought to be due to low expression and catalytic activity of the 
P450 enzyme during 72 h of incubation with both, the 
14
C-labelled substrate and inductor galactose, 
since it was previously demonstrated that this cell culture was capable to metabolize simazine under 
the same conditions. 
 
Figure 4.26: TLC radio-chromatogram of the cell extracts derived from NC and PY2c19 cell cultures 
incubated with 
14
C-p353-NP for 72 h.  
The PY2c19 cell culture did not metabolized p353-NP to a higher extent as compared to the NC cultures. The 
radioactivity in both cells extract was mainly due to parent p353-NP isomer (Peak 2) identified by co-
chromatography with an authentic reference. 
The cell extracts were also analyzed by HPLC using as references the corresponding non-labelled 
standard (results not shown). This analysis confirmed the radio-TLC results, indicating that in the 
present expression system, CYP2C19 was not able to metabolize p353-NP isomer in vivo. According 
to the literature on microsomes from cyp2c19-recombinant yeast, CYP2C19 was capable to 
metabolize 10% of the applied 4-n-nonylphenol and 29% of an applied mixture of branched 4-
nonylphenol isomers (Inui et al. 2001). This result is not in accord with my finding where no 
metabolic turnover was observed. One hypothesis for this difference in results could be that due to its 
substrate specificity, CYP2C19 enzyme is only capable to metabolize some branched isomers of 
nonylphenol but not the p353-NP examined in the present investigation. In fact the microsome system 
usen in the literature (Inui et al. 2001) demonstrated a different behaviour of this P450 species to 
metabolize linear nonylphenol on the one hand, and an isomer mixture, mainly composed of 2-(4-
hydroxyphenyl)-nonane, 3-(4-hydroxyphenyl)-nonane and 4-(4-hydroxyphenyl)-nonane on the other 
(Inui et al. 2001). The mixture examined was mainly composed of branched isomers with a tertiary 
carbon in !-position; the isomer used in my study, p353-NP, had a quaternary carbon in !-position 
and another tertiary carbon on the side chain (as shown in Fig. 4.24). This heavily branched structure, 
exhibiting a more compact molecular shape, could result in less accessibility to the active center of the 
enzyme CYP2C19, and this could ultimately cause a lower specificity of the enzyme for this 
nonylphenol isomer. To support this hypothesis more studies with my in vivo system should be 
performed comparing the metabolism of branched isomers with the linear 4-n-nonylphenol. 
4.2.1.2.2 Metabolism study of p353-NP by PY2b6 yeast cells culture 
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In vitro metabolism conduced in the recombinant yeast microsomes expressing CYP2B6 showed that 
the percentage of metabolized 4-n-NP was 16% (Inui et al. 2001). In this study the metabolism study 
was performed with the branched isomer p353-NP and in Fig. 4.19 its structure is reported. 
This study was performed by incubation of the NC and PY2b6 cell cultures for 72 h with 31 !g of 
14
C-
p353-NP (induction by galactose as described before). 
Fig. 4.27 shows the distributions of recovered radioactivity among cells and extracts of the media as 
well as the non-extractable radioactivity, NER1/2 (cf. Materials and Methods) concerning both 
cultures. The distributions of 
14
C were considerably different between the NC and PY2b6 cells. In fact 
in the NC, most of the radioactivity was present in the cell extracts (43%) followed by the NER 2 
portion (not extractable 
14
C present on paper filters after cell disruption; 22.3%); in the media, less 
than 7% of the applied radioactivity was present, and in the NER 1, a portion corresponding to 
approximately 10 % applied radioactivity was recovered. In the PY2b6 cell cultures, the majority of 
14
C was present in the extracts of the media (57%), followed by the cell extracts (14%). In the 
NER1/2, the portions of radioactivity found were less than 13% of the applied radioactivity.  
 
Figure 4.27: Balance of radioactivity observed after 72 h incubation in the metabolism studies using the 
NC and PY2b6 cell culture spiked with 
14
C-p353-NP. 
Distribution of 
14
C is shown between the different compartments. NC culture: higher portions of radioactivity 
were present in the cell extracts, followed by NER2 (non-extractable 
14
C on filters after cell disruption),; in 
media and in NER1 (non-extractable 
14
C on filters before cell disruption), the portion of radioactivity was 7% 
and 10%, respectively. PY2b6 culture: the radioactivity is mainly present in extracts of media (57%), followed 
by the cell extracts (14%); in NER1 and 2 the portions of radioactivity detected were less than 13%. 
The difference regarding portions of radioactivity present in the media was observed between the NC 
and PY2b6 cells cultures; this difference amounted to 52.7% in favour of the PY2b6 cells and was 
tentatively attributed to higher portions of hydrophilic metabolites produced by these cells. Total 
recovered radioactivity was approximately 90% with both cells cultures. Probably, this slight loss was 
due to the low aqueous solubility of nonylphenol and concomitant volatility from aqueous solution 
during 72h of incubation as previously described for methoxychlor. 
Media and cell extracts were analyzed by radio-TLC and the results are displayed in Fig. 4.28. The 
analysis clearly showed the presence of higher portions of metabolites of p353-NP in the cells culture 
expressing CYP2B6. 
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Figure 4.28: TLC radio-chromatograms of the extracts of the media (A) and cell extracts (B) derived from 
NC and PY2b6 cell cultures incubated with 
14
C-p353-NP for 72 h.  
The PY2b6 cell culture metabolized nonylphenol to a higher extent as compared to the NC cultures. (A) extract 
of media: in the NC cells, the radioactivity was mainly due to parent nonylphenol (Peak 2; identified by co-
chromatography with an authentic reference), whereas in the PY2b6 culture, nonylphenol was almost completely 
transformed in favour of more polar metabolites (peak 1). (B) cell extracts: in NC cell cultures, the major portion 
of 
14
C was due to non-metabolized nonylphenol (Peak 2), whereas in the PY2b6 cell cultures, only a small 
portion of applied nonylphenol remained non-metabolized. 
In the NC culture, nonylphenol was metabolized to a minor extent; thus, in media and in cell extracts 
the majority of radioactivity co-chromatographed with an authentic reference (Rf = 0.46) of 
nonylphenol (70% of 
14
C in extracts of media, 85% in cell extracts). In contrast, most of the 
radioactivity present in the extracts of the media derived from the PY2b6 culture was due to 
nonylphenol metabolites (Peak 1: 98% of 
14
C in media extract). In the cell extracts, the portion of non-
metabolized nonylphenol amounted to approximately 12% (Peak 2) and 84% of the radioactivity 
eluted as Peak 1. 
Extracts of media and cells were also analyzed by HPLC using as reference the corresponding non-
labelled standard; results are shown in Fig. 4.29. 
 
Figure 4.29: HPLC results of extracts of media and cells derived from NC and PY2b6 culture incubated 
with 
14
C-p353-NP for 72 h. 
Peak 1: p353-NP standard. In the extracts of media and cells derive from the NC cultures, no metabolites were 
detected, the radioactivity present consisted of p-353-nonylphenol (as determined by co-chromatography with a 
non-labelled standard; Peak 2). In the extract of the media derived from the PY2b6 cultures, the main metabolite 
was found in the more hydrophilic region of the chromatogram (Peak 3); a low portion of non-metabolized p353-
nonylphenol (Peak 5) and of a metabolite (Peak 4) were also detected. In the cell extracts of the PY2b6 cultures, 
a portion of non-metabolized p353-nonylphenol was detected (Peak 5); Peak 4 was a more hydrophilic 
metabolite of nonylphenol.  
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In the media and cells derived from the NC cultures, no metabolites were detected, and the 
radioactivity contained in the samples was mainly due to p353-NP (R.T. = 26.67 min). In the cell 
extracts from the PY2b6 cells, a portion of radioactivity was attributed to non-metabolized p353-
nonylphenol, and another peak (Peak 4) was detected in the more hydrophilic region of the 
chromatogram (R.T. = 23.7 min), indicating that this substance was more polar than p353-
nonylphenol. In the media extract, a small portion of radioactivity was found to co-chromatograph 
with non-metabolized p353-nonylphenol, while the main portion of radioactivity consisted of a more 
hydrophilic metabolite (Peak 3). This metabolite was found to be even more polar (R.T. = 16.89 min) 
than the metabolite found in the cell extracts (Peak 4).  
According to the literature on microsomes from Cyp2b6-recombinant yeast, CYP2B6 was capable to 
metabolize 16% of the applied 4-n-nonylphenol and 44% of an applied mixture of branched isomers of 
4-nonylphenol (Inui et al. 2001). These data can be compared to the present data in a qualitative but 
certainly only in a semi-quantitative manner, because concentrations of biomass (yeast cells vs. 
microsomes) and nonylphenol and duration of incubation differed between the two systems. 
Nevertheless in the present whole cell-system, the portion of non-metabolized nonylphenol remaining 
after 72 h of incubation was 4% of applied radioactivity according to radio-TLC and 7% according to 
HPLC analysis. These results point to a metabolic rate for nonylphenol of 93-96%. As already 
described for the metabolism study with methoxychlor, the main factor accounting for the difference 
in turnover between the in vivo- and in vitro-system was supposed to be the incubation period; 
experiments with microsomes are prevailingly limited to a few hours due to the limited lifetime of the 
proteins present in this artificial biochemical system. 
According to literature data, a microsomal in vitro system containing CYP2B6 was able to metabolize 
4-n-NP mainly to nonylquinol [4-hydroxy-4-nonyl-2,5-cycloexadien-1-one], OH-NP [1-(4’-
hydroxyphenyl)-nonan-ol]; furthermore, CYP2B6 showed the formation of CO-NP [4’-
hydroxynonanophenone] and hydroquinone (LITERATURE). Further experiments demonstrated that 
the amount of hydroquinone formed from OH-NP was larger than that from CO-NP. Therefore it was 
reasonable to assume that direct ipso-substitution of OH-NP to hydroquinone was the main metabolic 
pathway (Tezuka et al. 2007). Experiment conduced with human microsomal in vitro-system on the 
p363-NP isomer showed that the main metabolites were represented by catechol-nonylphenol and 
side-chain-hydroxlated-363-NP (Ye et al. 2007). In my system, I found two metabolites, more polar 
than p353-nonylphenol itself. I hypothesized that Peak 4, which was slightly more polar than p353-
nonylphenol, might have been a mono-hydroxylated metabolite (cathechol or hydroxylated-side chain) 
and Peak 3 might represent a poly-hydroxylated metabolite or hydroquinone. To support these 
hypothesis, a further metabolism study was performed by incubating the PY2b6 cells culture with a 
higher amount of p353-NP exhibiting a specific isotopic composition, as described below, in order to 
separate the two peaks identified by HPLC and analyze them via GC/MS.  
4.2.1.2.3 Metabolism study using the 
12
C/
13
C/
14
C-p353-NP isomer and the PY2b6 cell culture. 
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This study was performed by incubation of the NC and PY2b6 cell cultures for 72 h and 144 h with 30 
!g of 
14
C-p353-NP, 115 µg each of 
13
C- and 
12
C-p353-NP (induction by galactose as described 
before). The equimolar concentration of 
12
C- and 
13
C-p353-NP would generate a characteristic pattern 
(double peak of one mass unit of distance) in the mass spectra of the compound, allowing more easy 
identification of corresponding metabolites, while the radioactive portion would permit to follow the 
related compounbds during the metabolism study in a qualitative and quantitative manner. The results 
obtained for both metabolism studies (incubation for 72 h and 144 h) were similar; therefore the data 
obtained from the 72 h incubation are reported here. 
The total recovery of radioactivity was 93% in the PY2b6 cell cultures, in accordance with the value 
found in the previous experiment. The distributions of 
14
C were considerably different between the NC 
and PY2b6 cells, as already described before. In fact in the NC, most of the radioactivity was present 
in the cell extract (47%) followed by the NER 2 portion (not extractable 
14
C present on paper filters 
after cell disruption) (22%); in the media, less than 8% of the applied radioactivity was present, and in 
the NER 1, a portion amounting to approximately 9 % applied radioactivity was recovered. In the 
PY2b6 cell cultures, the majority of 
14
C was present in the extracts of the media (58%), followed by 
cell extracts (21%). In the NER1/2 the portion of radioactivity found was less than 14% of the applied 
radioactivity. 
Media and cell extracts were analyzed by radio-TLC (results not shown). Results of the analysis 
clearly showed the presence of higher portions of metabolites in the cells culture expressing CYP2B6, 
as previously described. 
Extracts of media and cells were also analyzed by HPLC using as reference the corresponding non-
labelled standard. In Fig. 4.30 the media extract analysis is reported. 
 
 
Figure 4.30: HPLC results of extracts derived from the media of the NC and PY2b6 cultures incubated 
with 
14
C-p353-NP for 72 h. 
Peak 1: R.T. = 16.91 min; Peak 2: R.T. = 23.72 min; Peak 3: p353-NP as determined by co-chromatography with 
a non-labelled standard; R.T. = 26.70 min. The peaks were separated using a preparative HPLC.  
The metabolites (Peak 1 and Peak 2) were separated and isolated by preparative HPLC and analyzed 
by GC/MS. Peak 2 (Fig. 4.30) had the same retenttion time as Peak 4 shown in Fig. 4.29; the higher 
amount of this metabolite in the media extract of this study (Fig. 4.30) compared to the previous one 
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(Fig. 4.29) could be due to the higher amount of p353-nonylphenol applied (10.4 times more), 
generating an higher metabolic rate to this biotransformation product. Samples of the media extract 
and the cell extract were chromatographed on the same plate to confirm the co-elution of Peak 2. 
Because the amount of radioactivity in the cell extract was approximately 20 %, and 44% of this 
portion was attributed to Peak 2, the portion of Peak 2 in the cells extract was approximately 4% of the 
applied p353-nonylphenol. On the contrary, the amount of radioactivity in the media extract was 
approximately 60% and of this 38% was attributed to Peak 2, corresponding to approximately 23% of 
the applied p353-nonylphenol. For these reasons, Peak 2 was isolated from the media extract and 
analyzed. 
According to previously published data on 4-n-NP and 4-NP isomers (Schmidt et al. 2003; Berger et 
al. 2005) the isolated HPLC fractions (Peak 1 and 2) were reacted with MSTFA to trimethylsilyl 
derivatives and examined by GC-EIMS. In Fig. 4.31, GC-EIMS chromatograms of the nonylphenol 
standard and of the two HPLC-fractions Peak 1 and Peak 2 are reported. The chromatogram of the two 
HPLC-fractions (Peak 1 and Peak 2) showed the presence of many compounds co-eluting with the 
p353-nonylphenol metabolites. Regarding the more polar fraction (Peak 1), an extremely high amount 
of peaks were present in the GC-chromatogram mainly due to media components and yeast 
fermentation products (such as sugars) making the identification of the p353-NP metabolites more 
difficult.  
In the HPLC-fraction Peak 2, two peaks (R.T. = ca. 18.50min) could unequivocally be traced back to 
metabolites of p353-NP, exhibiting the characteristic pattern of double peak with a mass unit 
difference of 1 due to the presence of a 
12
C/
13
C equimolar ratio. In Fig. 4.32, the mass spectra of these 
p353-nonylphenol metabolites are reported and compared to the mass spectra of the standard. 
 
A 
B 
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Figure 4.31: GC-EIMS chromatograms of the 
12
C/
13
C-p353-NP standard, and of the two HPLC fractions 
Peak 1 and Peak 2. 
A: Chromatogram of nonylphenol standard, 
12
C- and 
13
C-p353-NP equimolar ratio. B: Chromatogram of HPLC 
Peak 1. C: Chromatogram of HPLC Peak 2. All samples were reacted with MSTFA prior to analysis. 
The GC-EIMS chromatogram derived from HPLC peak 2 exhibited two peaks similar to that of the 
parent isomer p353-nonylphenol. Since the mass fragmentation patterns were quite similar, I suspected 
that the two peaks demonstrated presence of diastereomers. Prominent fragments of the metabolites – 
besides the molecular ion at m/z 380 - were m/z 360, 351, 309, 280, and 179.  Due to their mass 
spectra, the metabolites were identified as a side chain hydroxylated biotransformation product. 
According to the mass fragmentation, the position of the hydroxyl group was supposed to be attached 
to the methyl group located in !-position at the side chain. Furthermore the hydroxylation at several 
other positions at the chain would result in a third chiral centre, which ultimately would lead to four 
diastereoisomers. Since only two were obtained, this would argue for hydroxylation at one of the end 
positions of the side chain. The fragmentation of p353-NP was compared to the proposed 
fragmentation of the hydroxylated metabolites in Fig. 4.33. 
The presence of the fragment m/z 179 (trimethylsilyl derivatives of hydroxyl tropilium ion with m/z 
107) in the metabolites’ spectrA indicated that the hydroxylation occurred on the side-chain and not on 
the phenolic ring. The mass fragment at 309 m/z pointed to hydroxylation on the methyl  
A 
B 
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Figure 4.32: GC-EIMS chromatogram and mass spectra of p353-NP standard and HPLC-fraction Peak 2 
A: Mass spectrum of the equimolar mixture of the 
12
C/
13
C-p353-NP standard. B: GC-EIMS chromatogram of the 
metabolites contained in the HPLC-fraction Peak 2; the peak was identified by extracting the selected ions (380, 
365, 351, 280 and 179 m/z). C: Mass spectra of the metabolites in HPLC-fraction Peak 2. 
 
Figure 4.33: Proposed MS fragmentation of p353-NP (A) and its hydroxylated metabolite (B) 
 
or ethyl group present in !-position of the side-chain. The elimination of ethylene (281 m/z) indicated 
that hydroxylation had rather occured at the methyl group than at the ethyl group. This results would 
indicate a novel metabolite of nonylphenol isomer p353-NP. To confirm this hypothesis the mass 
spectra of the metabolites should be compared with a reference having the hypothesized structure.  
The analysis of the GC-EIMS of HPLC-fraction Peak 1 did not allow the identification of any 
compound that could be traced back to structures related to p353-NP. I suspected that considerably 
polar compounds were formed, which could not be analyzed by GC/MS only with difficulty. This 
hypothesis is supported by literature data which describe ipso-substitution of hydroxylated 
nonylphenol (Tezuka et al. 2007) to hydroquinone as already discussed in the previous paragraph. It is 
also possible that coumpounds were formed which were not chemically stable (e.g. thermally labile) 
during the gaschromatographic process. 
4.2.1.3 Metabolism studies using the yeast system 1 
The recombinant yeast cells cultures pT2b6 and pU2c19 were used to perform metabolism studies 
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respectively with simazine and the nonylphenol isomer p353-NP. 
4.2.1.3.1 Metabolism study using the pU2c19 cells and simazine with 72 h of incubation 
This study was performed by incubation of the NC and pU2c19 cell cultures for 72 h with 13 !g of 
14
C-simazine (induction by galactose as in Materials and methods). As negative control the non-
transformed yeast S. cerevisiae strain YH499 were used. 
Fig. 4.34 shows the distributions of recovered radioactivity among cells and extracts of the media 
concerning both cultures. The recovered radioactivity was mainly present in the extracts of the media 
of both, the NC and the pU2c19 cell cultures (approximately 100%). In the cell extract, below 1% of 
the applied radioactivity was present. The non extractable radioactivity (NER) – determined before 
and after cell disruption – amounted to less than 0.2%; for this reason, these data were not included in 
the graph. 
 
Figure 4.34: Balance of radioactivity observed after 72 h incubation in the metabolism study using NC 
and pU2c19 cell cultures spiked with 
14
C-simazine. 
The distributions of radioactivity between the compartments are reported: in both, the negative control (NC) and 
the recombinant culture (PY2c19) the radioactivity was mainly present in the media extract (ME), while in the 
cells extract (CE), only a small portion of radioactivity was present. 
The media extract was analyzed by radio-TLC and the results are shown in Fig. 4.35. 
 
Figure 4.35: TLC radio-chromatogram of the extracts of the media of the NC and the pU2c19 culture 
incubated with 
14
C-simazine for 72 h. 
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Both, the negative control and the recombinant cell culture transformed simazine in a similar manner and only to 
a low extent. The identity of the simazine was proven by co-chromatography with an authentic reference. (1) 
14
C 
remaining at the start of the plate; (2) 
14
C co-chromatographing with an authentic reference of deethyl-simazine; 
(3) 
14
C co-chromatographing with an authentic reference of simazine. 
The corresponding results demonstrated that the recombinant cell culture was not capable to 
metabolize simazine to a higher extent than the NC. The identity of simazine (detected with radio-
TLC) was proven by comparison (co-chromatography) with the Rf of an authentic non-labelled 
reference. Additionally, the samples were analyzed by means of HPLC HPLC using as references the 
corresponding non-labelled standard (results not shown). This analysis confirmed the radio-TLC 
results, indicating that this cells culture was not able to metabolize p353-NP isomer.  
This recombinant cells cultures pU2c19 was not able to metabolize simazine, while the system 
previously described (PY2c19) showed the presence of simazine-metabolites. This problem can 
possibly be related to the difference in the expression levels of the CPYR. In this case, the plasmid-
encoded yeast reductase was over-expressed (while in the previous one, the expression of CPYR was 
regulated at genomic level) and this could cause some cellular instability (e.g.: membrane integrity) 
that was not allowing for sufficient activity of the cytochrome P450. To support this hypothesis 
another metabolism study was performed using the pT2b6 cells culture in presence of p353-NP 
isomer; this substance was also metabolized using the previous yeast system. 
4.2.1.3.2 Metabolism study using the pT2b6 cells and p353-NP with 72 h of incubation 
This study was performed incubating the NC and the pT2b6 cell culture for 72 h with 30 !g of 
14
C-
p353-NP. Fig. 4.36 shows the distributions of recovered radioactivity among cells and extracts of the 
media as well as the non-extractable radioactivity, NER1/2 (cf. Materials and Methods) concerning 
both cultures. The distributions of 
14
C were not considerably different between the NC and pT2b6 
cells. In fact in both cell cultures, most of the radioactivity was present in the cell extracts (43% for 
both, the NC and pT2b6 cells culture), followed by those portions present in the NER 1 (not 
extractable 
14
C present on paper filters before cell disruption) (27% for NC and 18% for pT2b6 cells 
cultures). 
 
Figure 4.36: Balance of radioactivity observed after 72 h incubation in the metabolism studies using the 
NC and pT2b6 cell culture spiked with 
14
C-p353-nonylphenol. 
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Distribution of 
14
C is shown between the different compartments. In both cells cultures (NC and PY2c19) higher 
portions of radioactivity were present in the cell extracts followed by NER1 (non-extractable 
14
C on filters after 
cells disruption); in media and NER2 (non-extractable 
14
C on filters before cell disruption) portions of 
radioactivity were respectively less than 11 % and 21%. 
The similar distribution of radioactivity in the different compartments could indicate that there was no 
production of a higher portions of hydrophilic metabolites produced by the recombinant cells cultures, 
as it had occurred in the case of methoxychlor and p353-NP in the PY2b6 cell cultures. Total 
recovered radioactivity was approximately 90% with both cells cultures. 
 
 
Figure 4.37: TLC radio-chromatogram of the cell extracts derived from NC and pT2b6 cell cultures 
incubated with 
14
C-p353-NP for 72 h.  
The pT2c19 cell culture did not metabolize p353-NP to a higher extent as compared to the NC cultures. The 
radioactivity in both cells extract was mainly due to parent p353-NP isomer (Peak 2) identified by co-
chromatography with an authentic reference. 
The cell extracts were analyzed by radio-TLC and the results are displayed in Fig. 4.37. The analysis 
clearly showed that the cells culture putatively expressing CYP2B6 was not able to metabolize the 
p353-NP isomer. In fact, the radioactivity in both cultures was mainly due to the parent compound 
p353-NP isomer (~87%). Cell extracts were also analyzed by HPLC using as references the 
corresponding non-labelled standard (results not shown). This analysis confirmed the radio-TLC 
results, indicating that pT2b6 cells culture did not metabolize p353-NP to a higher extent than the NC 
culture. 
I previously demonstrated that the recombinant cells cultures PY2b6 and pY2c19 were able to 
metabolize respectively p353-NP and simazine; the cells cultures pT2b6 and pU2c19 did not 
metabolize these xenobiotics, therefore we can deduce that the different way of regulating the 
expression of the CPYR (and consequentially the different level of expression) could be the main 
reason for this difference. 
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4.3 Part B: chlorination of nonylphenol isomers and assessment of their xeno-
hormone potency 
4.3.1 Confirmation for the structures of the compounds used in this study.  
The chlorinated derivatives of NP isomers were produced by reaction of p-4nNP, p-33NP, p-353NP or 
p-363NP with SO2Cl2 and were purified by silica gel column chromatography and TLC. GC/MS 
analysis confirmed the purity of the compounds. Furthermore, GC/MS analysis proved that the 
chlorination occurred exclusively at the phenolic ring. The characteristic m/z of each NP isomer and 
their corresponding mono and di-chlorinated compounds are summarized in Table 1. The spectra of 
the chlorinated compounds are characterized by a shift, in all fragments, of 35 mass units for the 
MClNP and 70 for the DClNP as compared to the non chlorinated NP isomers. The presence of 
chlorine was indicated by the characteristic isotopic pattern; this pattern is present for all fragments of 
each chlorinated isomer reported in Table 4.3. According to recent high resolution mass spectra, the 
fragment at m/z 107 in the spectra of NP represents the hydroxyl-tropylium ion structure (Moeder et 
al. 2006). The fragment at m/z 107 is present in the spectra of all isomers of nonylphenol and occurs 
after rearrangement of the HOPhCH2
+
 form to the more stable C7H7OH. Substitution of the !-carbon 
atom with an additional alkyl group further stabilizes the tropylium ion due to the positive inductive 
effect (Thiele et al. 2004). The shift of this fragment to 141 m/z in the spectra of the mono-chlorinated 
and to 175 m/z in the spectra of the di-chlorinated derivatives of the linear and !-branched isomers 
indicates that the chlorine is bound to the phenolic ring. Because the hydroxyl group is ortho/para 
directing and the para position is occupied by the alkyl chain, the chlorination is strongly directed to 
the ortho position. 
Table 4.3: Typical ions in MS analysis of 4 isomers of NP and their chlorinated derivative 
 
 no Cl MCl DCl 
4n-NP 107, 220 141, 254 175, 288 
p33-NP 107, 121, 149, 191, 220 141, 155, 183, 225, 254 175, 189, 217, 259, 288 
p353-NP 107, 121, 135, 149, 191, 
220 
141, 155, 169, 183, 225, 
254 
175, 189, 203, 217, 259, 
288 
p363-NP 107, 121, 135, 149, 
191,220 
141, 155, 169, 183, 225, 
254 
175, 189, 203, 217, 259, 
288 
 
The NP isomers and the corresponding chlorinated derivatives were analyzed via 
1
H-NMR. In Table 2, 
the structure of one of the 4-n-NP isomers, its chlorinated derivatives and the assignments of the 
1
H-
NMR signals of the protons of the phenolic ring are shown. NMR analysis first, verified the purity of 
the synthesized chemical and secondly, confirmed the position of the chlorine on the phenolic ring. As 
  4. Results and discussion 
- 73 - 
expected, both the p-MClNP and p-DClNP were chlorinated in ortho position to the –OH. The results 
obtained from the other three NP isomers are not shown, because the 
1
H-NMR signals concerning the 
phenolic ring were similar to those shown in Table 4.4. 
Table 4.4: Name, structures and 
1
H NMR spectra of the phenolic ring for 4-n-NP and its Cl derivatives. 
 
Name 4-n-NP 4-n-MClNP 4-n-DClNP 
Structure 
   
1
H NMR/%H 
7.04 (d, J=8.55 Hz, H-2 
and H-4); 6.74 (d, 
J=8.54, H-1 and H-3); 
4.62 (s, -OH); 2.52 (t, 
J=7.78 Hz, 1’-CH2) 
7.14 (d, J=2.13 Hz, H-3); 
7.00 (dd, J=10.38 Hz, 
2.14 Hz, H-2); 6.93 (d, 
J=8.24 Hz, H-1); 5.37 (s, 
-OH); 3.51 (t, J=7.78 Hz, 
1’-CH2) 
7.08 (s, arom. H-1 and H-
2); 5.69 (s, -OH); 3.51 (t, 
J=7.78 HZ, 1’-CH2). 
4.3.2 YES (yeast estrogenic screen) assay and anti-YES (estradiol competition assay).  
In this study, the estrogenic potency of four isomers of NP and their corresponding mono- and di-
chlorinated compounds was assessed. In Fig.4.38, the S-type curves from the YES assay are reported. 
The estrogenic potency of the 4 isomers of NP was in the following: p353-NP > p4n-NP > p33-NP > 
p363-NP.  In Table 4.5 the EC50 concentrations of all chemicals tested by means of the YES assay. 
The p353-NP has been shown to be the isomer with the highest estrogenic potency, the least 
estrogenic active isomer was proved to be p363-NP (Table 4.5). 
Table 4.5: EC50 concentration in the YES expressed in !M of the tested compounds and corresponding 
95% interval of confidence. 
 
 Pure isomer MCl DCl 
4n-NP 0.87 (0.85-0.89) 53.05 (53.10-53.00) n.a. 
p33-NP 1.11 (1.02-1.21) 7.78 (6.89-8.79) 13.82 (12.87-14.84) 
p353-NP 0.20 (0.19-0.21) 3.03 (2.80-3.29) 4.86 (4.52-5.23) 
p363-NP 5.19 (4.85-5.56) 3.58 (3.39-3.78) 14.68 (11.58-18.60) 
 
In case of p4n-NP, p33-NP and p353-NP mono-chlorination of the phenolic ring resulted in a decrease 
of the estrogenic potencies of these three isomers. The p363-MClNP was slightly more estrogenic than 
the parent isomer. In contrast, all four di-chlorinated compounds examined, showed a dramatic 
decrease in the estrogenic activity as compared to the non-chlorinated isomers. In case of 4-n-DClNP 
no residual estrogenic activity was observed, therefore it was not possible to calculate its EC50 (Table 
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4.5).  
It has been previously reported that the four isomers of NP (4-nNP, p33-NP, p353-NP and p363-NP) 
show different estrogenic activity in the MVLN and E-screen assay (Preuss et al. 2006). 
In this study, the estradiol competition assay (anti-YES) was also performed (data not showed). None 
of the samples analyzed showed any capacity of competing with estradiol for the receptor binding. 
 
 
Figure 4.38: Estrogenic activity of the four NP isomers 4n-NP (A), p33-NP (B), p353-NP (C) and p363-NP 
(D) and their chlorinated derivatives in the YES.  
The chemicals were serially diluted in order to obtain a full dose-response curve. Blank values (B) were means 
of wells containing ethanol only.  Error bars represent the S.E.M. (Standard error of the mean). 
The commercially available technical mixtures of NP contain more than 20 para-substitute isomers of 
NP. These isomers are known to show different estrogenic activity (Preuss et al. 2006). Many of these 
isomers possess one or more chiral centers, generating enantiomers (e.g. p-33NP and p-363NP) and 
diastereomers (e.g. p-353 NP). Different diastereomers have diverse physical chemical properties and, 
as enantiomers, they can be differently biodegraded. Consequentially, in the environment, these 
compounds can behave differently and some of them can present dissimilar environmental persistence 
or some forms (e.g. diastereomer) can be less subjective to biodegradation, due to their bioavailability 
(Gundersen 2001), or have different toxicity and xenohormone potency (Beresford et al. 2000). The 
estrogenic potency of the p353-NP isomer examined in this study was comparable with the results 
obtained using the E-screen assay (Preuss et al. 2006). Drinking water systems in the world commonly 
rely on chlorine treatment as disinfection method, because chlorine is inexpensive and generally safe 
to use (Kuruto-Niwa et al. 2005). It was reported that several halogenated derivatives of NP and NP 
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ethoxylates were detected by LC/MS in the sludge and sediment samples from drinking water 
treatment plants (Petrovic et al. 2001; Petrovic et al. 2003). In the literature, contrasting data were 
presented, concerning the estrogenic activity of chlorinated technical mixtures of NP. Hu et al. 
reported using another yeast screen that some products contained in the chlorinated 4-NP solution 
(technical mixture) elicit anti-estrogenic activity (Hu et al. 2002). Other studies (Garcia-Reyero et al. 
2004; Kuruto-Niwa et al. 2005) pointed out that the mono-chlorinated mixture of different NP isomers 
showed a slightly lower estrogenic activity when assessed respectively in GFP expression system and 
RYA test than the parent compounds and the di-chlorinated showed 10 times lower estrogenic activity 
than the parent NP (Kuruto-Niwa et al. 2005). Furthermore they reported no anti-estrogenic activity 
for the mono- and di-chlorinated NP mixtures (Garcia-Reyero et al. 2004; Kuruto-Niwa et al. 2005). 
This difference of results might be due to different assays used and to the composition of the technical 
mixture of nonylphenol utilized in different studies, that may change according to the producer and 
consequentially, some isomers of NP may be present in different concentrations.  
Our results showed that the presence of two chlorines dramatically decreases the estrogenic activity of 
the parent compounds in accordance with other studies carried out on di-chlorinated mixtures of NP 
isomers (Kuruto-Niwa et al. 2005) . This may indicate that the presence of two chlorines on the 
phenolic ring decreases the capacity of this molecule to interact with the estrogen receptor with no 
dependence on structure of the side chain.  
The presence of one chlorine results in different estrogenic activity depending on the side chain 
structure: it can be reduced almost 20 times (p33-MClNP) or slightly increased (p363-MClNP) 
compared to the parent compound. This result is in contrast with other studies on mono-chlorinated 
mixtures of NP isomers (Kuruto-Niwa et al. 2005) that showed a decrease in estrogenic activity. This 
difference emphasizes the necessity of assessing the estrogenic potency of the single isomers, because 
results obtained from mixtures are not completely reliable due to a different composition provided by 
different producers (Preuss et al. 2006). From a structural point of view, it is possible to suppose that 
the presence of the chlorine in ortho may influence the folding of the nonyl chain, depending on its 
structure and this can lead to an increase or decrease in the binding to the ER.   
In this study, the chemical tested did not show any anti-estrogenic potency, according to results 
reported on mono- and di-chlorinated mixtures of NP isomers (Kuruto-Niwa et al. 2005). This shows 
that the anti-estrogenic activity found in some mixtures of NP chlorinated in aqueous media (Hu et al. 
2002) must be due to the presence of other degradation products formed by the reaction of sodium 
hypochlorite with technical mixtures of NP. Attention should be paid to by-products obtained after 
chlorination of mixtures of NP isomers, because the identification of anti-estrogenic compounds could 
give more detailed information about the mechanism of competition with E2. 
Our results show the importance to study the estrogenic activity of single isomers of NP and their 
corresponding chlorinated derivatives. First, because some compounds derived from oxidation during 
chlorination process can mask the estrogenic affect of the chlorinated derivatives of NP and secondly, 
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because technical mixtures have different composition depending on the producer (Russ et al. 2005) 
which may lead to inconsistent results. Finally, the environmental concentrations of the different 
isomers of NP can differ considerably from the corresponding concentrations found in different 
technical mixtures; this way leads to an incorrect assessment of the xenohormone potency of their 
corresponding derivatives. 
4.3.3 Chemical artifact: creeping.  
Of all compounds analyzed, only p-353NP was found to be toxic for yeast at the concentration of 
2.5x10
-4 
M. At this concentration, the yeast was not growing, resulting in clear yellow wells, while no 
estrogenic effect was detected. However, the blank rows (containing seeded medium only) on either 
side of the wells with NP added where also positive, indicating that the chemical was not restricted to 
the wells in which it was placed, but moved freely across the plate, as previously reported (Beresford 
et al. 2000). This resulted in an estrogenic response, but not in a toxic effect. Furthermore, this 
“creeping” effect was seen for all isomers of NP, but the increase in chlorination decreased the 
capacity of the chemical to move across the plate (see Figure 4.39). 
 
 
Figure 4.39: 96 wells plates of YES assay for the isomer p33-NP (A)  and its corresponding p33-DClNP 
(B).  
In both plates: row 1, E2 standard; rows 2,4,6,8, negative control (only medium seeded with yeast); in plate A 
rows 3,5,7 p33-NP; in plate B rows 3,5,7 p33-DClNP. In plate A there is a positive response in the negative 
control rows (2,4,6,8) in the wells adjacent to those with higher concentration of NP isomer (creeping effect). In 
plate B, the creeping effect is completely absent. 
4.3.4 YAS (Yeast Androgenic Screen) and anti-YAS (androgenic competition assay).  
In the present study the androgenic and antiandrogenic potency of the four different isomers of NP and 
their corresponding chlorinated derivatives were examined. 
There was no response for YAS screen for any of the compounds tested (results not showed). In 
Figure 4.40 the S-shaped curves of the anti-androgenic assay for all chemicals tested are reported.  
The p363-NP isomer and its corresponding chlorinated isomers showed almost no ability to inhibit the 
activity of the DHT.  The isomer showing higher anti-androgenic potency was p353-NP, followed by 
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4n-NP, p33-NP and p363-NP in accordance with the results obtained for the YES. The 4n-NP, p33-NP 
and p353-NP isomers showed higher anti-androgenic potency than their corresponding p-MClNP and 
p-DClNP; furthermore their p-DClNP derivatives showed the least capacity of binding to the 
androgenic receptor; even at the higher concentration these compounds were not able to inhibit 
completely the action of DHT. 
 
Figure 4.40: Anti-androgenic activity of the four isomers of NP (4n-NP, p33-NP, p353-NP, p363-NP) and 
their chlorinated derivatives, shown in four panels (A,B, C and D). 
With the exception of the blank (where only solvent was present), DHT was present throughout at a single 
concentration (1.25x10
-9 
M) and this produced a sub-maximal response. Serial dilution of the tested chemicals 
assessed their capacity of inhibiting the action of DHT. Blank values (A) are means of wells containing ethanol 
only.  Error bars represent the S.E.M. (Standard error of the mean). 
Estrogen and androgen generally act by binding at receptor sites, and chemicals may disrupt this 
action in many ways (Sohoni and Sumpter 1998). For example a chemical may mimic the action of a 
natural ligand by being able to act on this receptor site, or it may interfere with the receptor in some 
other way and be able to block the action of the hormone (Sohoni and Sumpter 1998). One chemical 
can have a different number of mechanisms of action: o,p’-DDT was demonstrated to be a weak 
estrogen (Bitman et al. 1968), but it also possesses anti-androgenic activity (Kelce et al. 1995). 
Similarly, a number of alkylphenols were initially shown to be weak estrogen active compounds 
(White et al. 1994), have also been shown to be anti progestagenic (Tran et al. 1996). Several 
xenobiotic chemicals proved to possess anti-androgenic activity (Sohoni and Sumpter 1998). 
Sohoni and Sumpter tested the isomer 4n-NP, but no response was found for anti-androgenic activity 
(Sohoni and Sumpter 1998); however, the concentration range tested was lower than the range 
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investigated in the present study. Furthermore, anti-androgenic response of the chemical occurred in a 
range of concentrations similar to those of estrogenic activity.  
More studies should be assessed to gain a better understanding of the mechanism of action of 
xenohormones having two (or more) types of activity. The in vitro tests can only give estimation about 
the xeno-hormone potency of each chemical and the results obtained should be confirmed in vivo; this 
study, anyway, showed the importance of assessing the xenohormone potency of pure compounds 
against the use of technical mixtures of NP. 
This might be due to the increase in molecular weight of di-chlorinated NP or increased polarity of the 
molecule with a consequent increase in solubility in water. 
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5 Conclusions 
5.1 Part A: Metabolism studies of different xenobiotic using Saccharomyces 
cerevisiae transformed with human cytochromes P450 Cyp2b6 and Cyp2c19. 
 
1. The first aim of the present work was to establish a recombinant yeast cell culture, able to 
express the human proteins CYP2C19 and CYP2B6 (cytochromes P450) for model 
degradation studies  
 
2. Two different systems using the yeast Saccharomyces cerevisiae were created, having a 
different expression level of yeast reductase cytochrome P450 (YR). 
 
3. System 1: the YR and the cytochrome P450 monooxygenase were inserted in one plasmid 
under the control of a strong galactose-inducible promoter. The vector was used to transform 
the yeast and in this way the two genes were over-expressed in the yeast cell cultures pT2b6 
and pU2c19. 
 
4. System 2: the YR was regulated at a genomic level in the yeast under the control of a strong 
galactose-inducible promoter (system obtained from Dr. Pompon, France). The cytochrome 
P450 monooxygenase was inserted in a vector and this construct was used to transform the 
yeast. In this way, only the cytochrome P450 monooxygenase was over-expressed in the yeast 
cells cultures PY2b6 (expressing Cyp2b6) and PY2c19 (expressing Cyp2c19). 
 
5. To verify protein expression and activity, model metabolism experiments were executed using 
the yeast cells culture PY2c19 (system 2) with the substrate simazine (herbicide). 
 
6. After 72h of incubation with simazine in presence of the inducer galactose, the Cyp2c19-
recombinant cells culture was capable to metabolize simazine.  
 
7. This cells culture showed the ability of metabolize simazine mostly to a more polar 
compound, which according to the HPLC retention time was supposed to be hydroxy-
simazine. 
 
8. To verify protein expression and activity, first model metabolism experiments were executed 
using the yeast cells culture PY2b6 (system 2) with the substrates methoxychlor (insecticide). 
 
9. After 72h of incubation with methoxychlor in presence of the inducer galactose, the Cyp2b6-
recombinant cells culture was capable to metabolize methoxychlor. 
 
10. This cells culture showed the ability of metabolize methoxychlor mostly to the more polar 
compound catechol-methoxychlor according to HPLC data. 
 
11. The yeast cells cultures expressing CYP2B6 and CYP2C19 (PY2b6 and PY2c19) were used 
to perform metabolism studies with a branched isomer of nonylphenol, namely p353-NP (4-
(3’,5’-dimethyl-3’heptyl)-phenol). 
 
12. The yeast cells culture PY2c19 was not capable to metabolize p353-NP. I hypothesized that 
this highly branched structure was less susceptible to degradation by this P450 species. 
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13. The yeast cells PY2b6 was capable to metabolize p353-NP. HPLC analysis showed the 
presence of two peaks and they were analyzed by GC-EIMS. One of these peaks was refered 
to a metabolite hydroxylated at the side-chain. The second HPLC-peak, could not be identified 
by GC-EIMS analysis. It was supposed to to consist of a more polar compound such as 
hydroquinone, as suggested by a review of the literature. 
 
14. The same experiments were performed using the yeast system 1 (yeast cells cultures pT2b6 an 
pU2c19), but no transformation of simazine and nonylphenol occurred in these systems. I 
hypothesized that over-expression of the YR might be the problem for correct function of the 
P450 enzymes CYP2B6 and CYP2C19. 
 
15. All the experiments performed showed that the metabolism study performed with yeast 
systems was fast and reliable and allowed the screening of many xenobiotics for identification 
of their metabolites.  
 
5.2 Part B: Synthesis of different chlorinated isomers of nonylphenol and 
assessment of their xeno-hormone potency. 
 
1. The second aim of the present work was to assess the xeno-hormone potency of different pure 
isomers of NPs and their mono-chlorinated and di-chlorinated derivatives. 
 
2. Four nonylphenol isomers were synthesized and purified (p4n-NP, p33-NP, p353-NP and 
p363-NP). 
 
3. Their corresponding mono- and di-chlorinated derivatives were synthesized and purified, and 
their structures were confirmed by GC-EIMS and 
1
H-NMR analysis. 
 
4. These compounds were used to perform tests to assess their xeno-hormone potency, using the 
yeast estrogenic and androgenic screen (YES and YAS). 
 
5. p353-NP and p4n-MClNP (4-(3’,5’-dimethyl-3’heptyl)-phenol and 2-chlor-4-nonyl-phenol) 
showed the highest and the lowest estrogenic potency, respectively among all compounds 
tested. The p363-MClNP (2-chlor-4-(3’,6’-dimethyl-3’-heptyl)-phenol) exhibited estrogenic 
potency comparable to that of the parent isomer; all dichlorinated nonylphenol (p-DClNP) 
compounds showed a considerably lower estrogenic potency than the parent compounds. 
 
6. All substances exhibited a positive response in the anti-androgenic screen. The isomer p363-
NP (4-(3’,6’-dimethyl-3’heptyl)-phenol) and its corresponding mono and di-chlorinated 
derivative was almost inactive; the other compounds showed positive responses, but the 
mono- and di-chlorinated derivatives exhibit lower anti-androgenic potency. 
 
7. My results indicate that for a better understanding of the xero-hormone potency of chlorinated 
NPs the use of pure compounds is mandatory. 
 
 
  6. Abstract 
- 81 - 
6 Abstract 
The purpose of this study was to obtain a better understanding of the behaviour, the characteristics, the 
metabolism and the metabolites or derivatives of 4-nonylphenol isomers (4NP) regarding the risk of 
exposure for human health to these compounds.  
The development of efficient molecular tools, making it possible to analyze individual bioconversion 
steps by well-characterized enzymes, such as cytochrome P450 monooxygenases, appeared critical for 
valuable toxicological predictions.  
The first aim of the present work was to establish a recombinant yeast cell culture, able to express the 
human proteins CYP2C19 and CYP2B6 (cytochromes P450) for model degradation studies. Two 
different systems were created: 
• System 1: the YR and the cytochrome P450 monooxyigenase were inserted in one plasmid under 
the control of a strong galactose-inducible promoter. The vector was used to transform the yeast 
and in this way the two genes would be over-expressed in the yeast cells cultures pT2b6 
(expressing Cyp2b6) and pU2c19 (expressing Cyp2c19). 
• System 2: the YR was regulated at a genomic level in the yeast under the control of a strong 
galactose-inducible promoter (system obtained from Dr. Pompon, France). The cytochrome P450 
monooxygenase was inserted in a vector and this construct was used to transform the yeast. In this 
way only the cytochrome P450 monooxygenase was over-expressed in the yeast cells cultures 
PY2b6 (expressing Cyp2b6) and PY2c19 (expressing Cyp2c19). 
The transgenic yeast cell cultures were necessary in order to perform metabolism studies with 4-NP 
isomer. To verify protein expression and activity, model metabolism experiments were executed with 
the substrates simazine (herbicide) and methoxychlor (insecticide), for which information regarding 
transformation by human CYP2C19 and CYP2B6 were published in the literature using yeast system 
2. The yeast cells transformed with Cyp2c19 showed the ability of metabolize simazine to a more 
polar compound, which according to the HPLC retention time was supposed to be hydroxy-simazine. 
The yeast cell culture transformed with Cyp2c6 showed the ability of metabolize methoxychlor to the 
more polar compound catechol-methoxychlor according to HPLC data. This system was then used to 
perform metabolism studies with a branched isomer of nonylphenol, p353-NP (4-(3’,5’-dimethyl-
3’heptyl)-phenol). The yeast cells culture PY2c19 was not capable to metabolize this branched isomer, 
while PY2b6 was. HPLC analysis showed the presence of two peaks, one was identified by GC-EIMS 
analysis as a side chain hydroxylated metabolite, while the other HPLC peak could not be identified. 
The system 1 (pU2c19 and pT2b6 cells cultures) was used to perform the same metabolism studies, 
but in the recombinant cell cultures were not capable to metabolize applied simazine and nonylphenol.  
In vivo metabolism studies using recombinant yeast transformed with human P450s were proven to be 
fast, reliable and reproducible, and were therefore suitable for screening the metabolism of different 
xenobiotics. 
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NPs were detected in drinking water and wastewater, therefore they are subjected to all disinfection 
processes during the preparation of drinking water and during processes in wastewater treatment 
plants. The disinfection procedure often includes the use of sodium hypochlorite; during this process 
many by-products can be produced including chlorinated derivatives of NPs. 
Thus, the second aim of the present work was, to assess the xeno-hormone potency of different pure 
isomers of NPs and their mono-chlorinated and di-chlorinated derivatives. I reported the defined 
mono- and di-chlorination of four discrete NP isomers and the evaluation of their relative estrogenic 
and androgenic potency using a yeast screen. p353-NP (4-(3’,5’-dimethyl-3’heptyl)-phenol) and p4n-
MClNP (2-chlor-4-nonyl-phenol) isomers showed the highest and the lowest estrogenic potency, 
respectively among all compounds examined. The p363-MClNP (2-chlor-4-(3’,6’-dimethyl-3’-
heptyl)-phenol ) estrogenic potency comparable to the parent non-chlorinated isomer; all the 
dichlorinated compounds (p-DClNP) showed a considerably lower estrogenic potency than the parent 
compounds. All substances exhibited a positive response in the anti-androgenic screen. The isomer 
p363-NP (4-4-(3’,6’-dimethyl-3’heptyl)-phenol and its corresponding mono and di-chlorinated 
derivative were almost inactive; the other compounds showed positive response, but the mono- and di-
chlorinated derivatives exhibit lower anti-androgenic potency. My results indicated that for better 
understanding of the xero-hormone potency of chlorinated NP isomers the use of pure compounds is 
mandatory. In fact, the environmental concentrations of the different NP isomers can differ from the 
composition of the technical mixtures themselves (e.g. due to degradation and adsorption processes), 
leading to an incorrect xero-hormone potency assessment of their corresponding derivatives. 
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9.1 Annex A: Abbreviations 
APS    Ammonium persulphate 
Bis-OH-M   Bis-OH-Methoxychlor 
Cathecol-M   Cathecol-Methoxychlor 
DNA    DesossiriboNucleic Acid 
dpm    disintegration per minute 
EDTA    Ethylendiamintetraacetate 
FAD    flavin adenine dinucleotide 
FMN    Flavin mononucleotide or riboflavin-5?-phosphate 
h    hours 
min.    minutes 
Mono-OH-M   Mono-OH-methoxychlor 
MSTFA   (N-Methyl-N-trifluoroacetamide) 
o.n.    over night 
rpm    revolution per minute 
SDS    Sodium-dodecylsulphate 
Taq    Termus aquaticus DNA-polymerase 
Tris-OH-M   Tris-OH-Methoxychlor 
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environment, 15-19 August 2005, Denmark. 
Award as best poster in the Environmental chemistry section at the conference 
“Micropol & Ecohazard 2007” in Frankfurt, 17-20 June 2007 with the title: “Effect 
of chlorination on the estrogenic activity of different isomers of nonylphenol” 
Submitting to international journal a scientific paper entitled “ Different isomers of 
nonylphenol and their chlorinated derivatives differ in estrogenic and androgenic 
activity”  
  
Computer skills and 
competences 
The several reports about the experiment carried out during my studies and my 
thesis made me really expert in the Microsoft Office software, iWork (Mac) 
Photoshop CS2/CS3 (Windows and Mac), Invitrogen NTI, Chemdraw.  
Good knowledge of Windows and Apple environment. 
  
Artistic skills and 
competences 
Drawing and photograph. Photographic class was taken from 2nd of May 2008 
until 15th of July 2008 
  
Driving licence Driving licence B 
  
